首页 > 图书详情

致命流感:百年治疗史 历史地理类;专著;传染病学 VIP

售价:¥46.92 ¥69
4人在读 |
0 评分
丛书名:
[美]杰里米·布朗(Jeremy Brown) 王晨瑜   社会科学文献出版社  2020-03 出版
ISBN:978-7-5201-5998-2

*温馨提示:此类商品为数字类产品,不支持退换货,不支持下载打印

图书简介 目录 参考文献 音频 视频
1918年的流感大流行是一段令人毛骨悚然的历史,是有史以来死亡人数最多的全球性瘟疫,造成5000万至一亿人丧生,超过5亿人被感染。百年间,人类对流感病毒有了深入的了解,但仍然无法阻止和战胜这个“连环杀手”。流感为什么难以治愈?病毒如何变异、传播和致病?我们距离找到一种有效的流感疫苗还有多远?《致命流感》旨在提供全面综合的历史的同时,探索一条治愈流感的未来路线图。
[展开]
[1]Abhimanyu and A. K. Coussens. “The Role of UV Radiation and Vitamin D in the Seasonality and Outcomes of Infectious Disease”. Photochemical and Photobiological Sciences 16,no.3 (2017):314-38. [2]Adams,F. The Genuine Works of Hippocrates. New York:William Wood,1886. [3]Aimone,F. “The 1918 Influenza Epidemic in New York City:A Review of the Public Health Response”. Public Health Reports 125,suppl.3 (2010):71-79. [4]Almond,D. “Is the 1918 Influenza Pandemic Over?Long-Term Effects of InUtero Influenza Exposure in the Post-1940 U.S. Population”. Journal of Political Economy 114,no.41 (2006):672-712. [5]Andrews,C. The Common Cold. New York:W. W. Norton,1965. [6]Barry,J. M. The Great Influenza:The Epic Story of the Deadliest Plague in History. New York:Penguin,2005. [7]Barry,J. M. “The Site of Origin of the 1918 Influenza Pandemic and Its Public Health Implications”. Journal of Translational Medicine 2,no.1 (2004):3. [8]Bergman,P.,A. U. Lindh,L. Bjorkhem-Bergman,and J. D. Lindh. “Vitamin Dand Respiratory Tract Infections:A Systematic Review and Meta-analysis of Randomized Controlled Trials”. PLoS One 8,no.6 (2013):e65835. [9]Blair,G. The Trumps:Three Generations That Built an Empire. New York:Touchstone,2000. [10]Boland,M. E.,S. M. Roper,and J. A. Henry. “Complications of Quinine Poisoning”. Lancet 325,no.8425 (1985):384-85. [11]Brett,A. S.,and A. Zuger.,“The Run on Tamiflu—Should Physicians Prescribeon Demand?” New England Journal of Medicine 353,no.25 (2005):2636-37. [12]Bridges,C. B.,W. W. Thompson,M. I. Meltzer,G. R. Reeve,W. J. Talamonti,N. J. Cox,H. A. Lilac,H. Hall,A. Klimov,and K. Fukuda. “Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults:A Randomized Controlled Trial”. JAMA 284,no.13 (2000):1655-63. [13]Brownstein,J. S.,C. J. Wolfe,and K. D. Mandl.,“Empirical Evidence for the Effect of Airline Travel on Inter-regional Influenza Spread in the United States”. PLoS Medicine 3,no.10 (2006):e401. [14]Butler,D.,“When Google Got Flu Wrong”. Nature 494,no.7436 (2013):155-56. [15]Byerly,C.,Fever of War:The Influenza Epidemic in the U.S. Army during WorldWar I. New York:New York University Press,2005. [16]Cannell,J. J.,R. Vieth,J. C. Umhau,M. F. Holick,W. B. Grant,S. Madronich,C. F.,Garland,and E. Giovannucci. “Epidemic Influenza and Vitamin D”. Epidemiology & Infection 134,no.6 (2006):1129-40. [17]Cello,J.,A. V. Paul,and E. Wimmer. “Chemical Synthesis of Poliovirus cDNA:Generation of Infectious Virus in the Absence of Natural Template”. Science297,no.5583 (2002):1016-18. [18]Centers for Disease Control and Prevention. “Update:Drug Susceptibility of Swine-Origin Influenza A (H1N1)Viruses,April 2009”. Morbidity and Mortality Weekly Report 58,no.16 (2009):433-35. [19]Chartrand,C.,M. M. Leeflang,J. Minion,T. Brewer,and M. Pai. “Accuracy of Rapid Influenza Diagnostic Tests:A Meta-analysis”. Annals of Internal Medicine 156,no.7 (2006):500-11. [20]Collier,R. The Plague of the Spanish Lady:The Influenza Pandemic of 1918-1919. London:Macmillan,1974. [21]Cook,S.,C. Conrad,A. L. Fowlkes,and M. H. Mohebbi. “Assessing Google FluTrends Performance in the United States during the 2009 Influenza Virus A (H1N1)Pandemic”. PLoS One 6,no.8 (2011):e23610. [22]Cooper Cole,C. E. “Preliminary Report on Influenza Epidemic at Bramshott inSeptember-October,1918”. British Medical Journal 2,no.3021 (1918):566-68. [23]Creighton,C. A History of Epidemics in Britain. New York:Barnes & Noble,1965. [24]Crosby,A. W. America’s Forgotten Pandemic:The Influenza of 1918. Cambridge:Cambridge University Press,2003. [25]Das,D.,K. Mertzger,R. Heffernan,S. Balter,D. Weiss,and F. Mostashari. “Monitoring Over-the-Counter Medication Sales for Early Detection of Disease Outbreaks—New York City”. MMWR Supplements 54 (2005):41-46. [26]Debauche,L. Reel Patriotism:The Movies and World War I. Madison:Universityof Wisconsin Press,1997. [27]Demicheli,V.,T. Jefferson,L. A. Al-Ansary,E. Ferroni,and C. Di Pietrantonj. “Vaccines for Preventing Influenza in Healthy Adults”. Cochrane Database of Systematic Reviews 3 (2014):CD001269. [28]Dobson,J.,R. J. Whitley,S. Pocock,and A. S. Monto. “Oseltamivir Treatment for Influenza in Adults:A Meta-analysis of Randomised Controlled Trials”. Lancet 385,no.9979 (2015):1729-37. [29]Doshi,P. “The Elusive Definition of Pandemic Influenza”. Bulletin of the World Health Organization 89 no.7 (2011):532-38. [30]Doshi,P. “The 2009 Influenza Pandemic”. Lancet Infectious Diseases 13,no.3 (2013):193. [31]Dow,K.,and S. Cutter. “Crying Wolf:Repeat Responses to Hurricane EvacuationOrders”. Coastal Management 26,no.4 (1998):237-52. [32]Duncan,K. Hunting the 1918 Flu:One Scientist’s Search for a Killer Virus. Toronto:University of Toronto Press,2003. [33]Earn,D. J.,P. W. Andrews,and B. M. Bolker. “Population-Level Effects of Suppressing Fever”. Proceedings of the Royal Society B:Biological Sciences 281,no.1778 (2014):20132570. [34]Edmond,J. D.,R. G. Johnston,D. Kidd,H. J. Rylance,and R. G. Sommerville. “The Inhibition of Neuraminidase and Antiviral Action”. British Journal of Pharmacology and Chemotherapy 27,no.2 (1966):415-26. [35]Emerman,M.,and H. S. Malik. “Paleovirology—Modern Consequences of AncientViruses”. PLoS Biology 8,no.2 (2010):e1000301. [36]Emerman,M.,and H. S. Malik. “The Epidemic of Influenza”. JAMA 71,no.13 (1918):1063-64. [37]Evans,S. S.,E. A. Repasky,and D. T. Fisher. “Fever and the Thermal Regulation of Immunity:The Immune System Feels the Heat”. Nature Reviews Immunology 15,no.6 (2015):335-49. [38]Eyler,J. M. “The State of Science,Microbiology,and Vaccines circa 1918”. Public Health Reports 125,suppl.3 (2010):27-36. [39]Fabier,F. “Traitement de la Grippe par les Injections de Quinine”. Journal de Médecineet de Chirurgie Pratiques 90 (1919):783-84. [40]Fiore,A. E.,T. M. Uyeki,K. Broder,L. Finelli,G. L. Euler,J. A. Singleton,J. K. Iskander et al. “Prevention and Control of Influenza with Vaccines:Recommendations of the Advisory Committee on Immunization Practices (ACIP),2010”. MMWR Recommendations and Reports 59,no. RR-8 (2010):1-62. [41]Garrett,T. “Pandemic Economics:The 1918 Influenza and Its Modern-Day Implications”. Federal Reserve Bank of St. Louis Review 90,no.2 (2008):75-93. [42]Garrett,T. “War and Pestilence as Labor Market Shocks:U.S. Manufacturing WageGrowth 1914-1919”. Economic Inquiry 47,no.4 (2009):711-25. [43]Gaydos,J. C.,F. H. Top Jr.,R. A. Hodder,and P. K. Russell. “Swine Influenza AOutbreak,Fort Dix,New Jersey,1976”. Emerging Infectious Diseases 12,no.1 (2006):23-28. [44]Gerdil,C. “The Annual Production Cycle for Influenza Vaccine”. Vaccine 21,no.16 (2003):1776-79. [45]Glatstein,M.,and D. Scolnik. “Fever:To Treat or Not to Treat?” World Journal of Pediatrics 4,no.4 (2008):245-47. [46]Godlee,F. “Conflicts of Interest and Pandemic Flu”. British Medical Journal 340 (2010):c2947. [47]Gregor,A. “A Note on the Epidemiology of Influenza among Workers”. British Medical Journal 1,no.3035 (1919):242-43. [48]Grijalva,C. G.,J. P. Nuorti,and M. R. Griffin. “Antibiotic Prescription Rates for Acute Respiratory Tract Infections in U.S. Ambulatory Settings”. JAMA 302,no.7 (2009):758-66. [49]Grist,N. R. “Pandemic Influenza 1918”. British Medical Journal 2,no.6205 (1979):1632-33. [50]Gross,C. P.,and K. A. Sepkowitz. “The Myth of the Medical Break through:Small pox,Vaccination,and Jenner Reconsidered”. International Journal of Infectious Disease 3,no.1 (1998):54-60. [51]Hammond,G. W.,R. L. Raddatz,and D. E. Gelskey. “Impact of Atmospheric Dispersionand Transport of Viral Aerosols on the Epidemiology of Influenza”. Reviews of Infectious Diseases 11,no.3 (1989):494-97. [52]Hammond,J. A. B.,W. Rolland,and T. H. G. Shore. “Purulent Bronchitis:A Studyof Cases Occurring amongst the British Troops at a Base in France”. Lancet 190,no.4898 (1917):41-45. [53]Hannoun,C. “The Evolving History of Influenza Viruses and Influenza Vaccines”. Expert Review of Vaccines 12,no.9 (2013):1085-94. [54]Hawkes,N. “Sharp Spike in Deaths in England and Wales Needs Investigating,Says Public Health Expert”. British Medical Journal 352 (2016):i981. [55]Hayden,F. G.,J. J. Treanor,R. F. Betts,M. Lobo,J. D. Esinhart,and E. K. Hussey. “Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza”. JAMA 275,no.4 (1996):295-99. [56]Henderson,D. A.,B. Courtney,T. V. Inglesby,E. Toner,and J. B. Nuzzo. “Public Health and Medical Responses to the 1957-58 Influenza Pandemic”. Biosecurityand Bioterrorism 7,no.3 (2009):265-73. [57]Herfst,S.,E. J. Schrauwen,M. Linster,S. Chutinimitkul,E. De Wit,V. J. Munster,E. M. Sorrell et al. “Airborne Transmission of Influenza A/H5N1 Virus between Ferrets”. Science 336,no.6088 (2012):1534-41. [58]Hernan,M. A.,and M. Lipsitch. “Oseltamivir and Risk of Lower RespiratoryTract Complications in Patients with Flu Symptoms:A Meta-analysis of Eleven Randomized Clinical Trials”. Clinical Infectious Diseases 53,no.3 (2011):277-79. [59]Herrick,J. B. “Treatment of Influenza by Means Other Than Vaccines and Serums”. JAMA 73,no.7 (1919):482-87. [60]Hiam,L.,D. Dorling,D. Harrison,and M. McKee. “What Caused the Spike in Mortality in England and Wales in January 2015?” Journal of the Royal Society of Medicine 110,no.4 (2017):131-37. [61]Hildreth,M. L. “The Influenza Epidemic of 1918-1919 in France:Contemporary Concepts of Aetiology,Therapy,and Prevention”. Social History of Medicine 4,no.2 (1991):277-94. [62]Hirani,V.,and P. Primatesta. “Vitamin D Concentrations among People Aged 65 Years and Over Living in Private Households and Institutions in England:Population Survey”. Age and Ageing 34 no.5 (2006):485-91. [63]Hirve,S.,L. P. Newman,J. Paget,E. Azziz-Baumgartner,J. Fitzner,N. Bhat,K. Vandemaele,and W. Zhang. “Influenza Seasonality in the Tropics and Subtropics—When to Vaccinate?” PLoS One 11,no.4 (2016):e0153003. [64]Honigsbaum,M. “Regulating the 1918-19 Pandemic:Flu,Stoicism and theNorthcliffe Press”. Medical History 57,no.2 (2013):165-85. [65]Hopkirk,A. F. Influenza:Its History,Nature,Cause and Treatment. New York:Walter Scott Publishing,1914. [66]Hoyle,F.,and C. Wickramasinghe. Evolution from Space:A Theory of Cosmic Creationism.New York:Simon & Schuster,1982. [67]Hoyle,F.,and N. C. Wickramasinghe. “Sunspots and Influenza”. Nature 343,no.6256 (1990):304. [68]Hughes,S. S. The Virus:A History of the Concept. London:Heinemann Educational Books,Science History Publications,1977. [69]Influenza Committee of the Advisory Board to the D.G.M.S.,France. “The Influenza Epidemic in the British Armies in France,1918”. British Medical Journal 2,no.3019 (1918):505-9. [70]“Influenza Discussions”. American Journal of Public Health 9,no.2 (1919):136. [71]“Influenza:Its History,Nature,Cause and Treatment”. Book review. JAMA 63,no.3 (1914):267. [72]“Influenza:Kansas—Haskell”. Public Health Reports 33,no.14 (1918):502. [73]Jack,A. “Flu’s Unexpected Bonus”. British Medical Journal 339 (2009):b3811. “James B. Herrick (1861-1954)”. JAMA 16,no.186 (1963):722-23. [74]Jefferson,T. “Influenza Vaccination:Policy versus Evidence”. British Medical Journal 333,no.7574 (2006):912-15. [75]Jefferson,T.,V. Demicheli,D. Rivetti,M. Jones,C. Di Pietrantonj,and A. Rivetti. “Antivirals for Influenza in Healthy Adults:Systematic Review”. Lancet 367,no.9507 (2006):303-13. [76]Jefferson,T.,and P. Doshi. “Multisystem Failure:The Story of Anti-influenza Drugs”. British Medical Journal 348 (2014):g2263. [77]Jefferson,T.,M. A. Jones,P. Doshi,C. B. Del Mar,R. Hama,M. J. Thompson,E. A. Spencer et al. “Neuraminidase Inhibitors for Preventing and Treating Influenza in Healthy Adults and Children”. Cochrane Database of Systematic Reviews 4 (2014):CD008965. [78]Jenner,E. An Inquiry into the Causes and Effects of the VariolaeVaccinae,a Disease Discovered in Some of the Western Counties of England,Particularly Gloucestershire,and Known by the Name of the Cow Pox. London:Sampson Low,1798. [79]Kaiser,L.,C. Wat,T. Mills,P. Mahoney,P. Ward,and F. Hayden. “Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complicationsand Hospitalizations”. Archives of Internal Medicine 163,no.14 (2003):1667-72. [80]Kamat,S.,V. Maniaci,M. Y. Linares,and J. M. Lozano. “Pediatric Psychiatric Emergency Department Visits during a Full Moon.” Pediatric Emergency Care 30,no.12 (2014):875-78. [81]Kelly,H.,and K. Grant. “Interim Analysis of Pandemic Influenza (H1N1)2009 in Australia:Surveillance Trends,Age of Infection and Effectiveness of SeasonalVaccination”. Eurosurveillance 14,no.31 (2009):1-5. [82]Kennedy,D. “Better Never Than Late”. Science 310,no.5746 (2005):195. [83]Khan,A.,and W. Patrick. The Next Pandemic:On the Front Lines against Humankind’s Gravest Dangers. New York:Public Affairs,2016. [84]Kilbourne,E. D. “Influenza Pandemics of the 20th Century”. Emerging Infectious Diseases 12,no.1 (2006):9-14. [85]Klein,H. A. “The Treatment of ‘Spanish Influenza’”. JAMA 71,no.18 (1918):1510. [86]Kluger,M. J. Fever:Its Biology,Evolution,and Function. Princeton,NJ:Princeton University Press,1979. [87]Kmietowicz,Z. “Use Leftover Tamiflu to Grit Icy Roads,MP Suggests”. British Medical Journal 340 (2010):c501. [88]Kochanek,K. D.,S. L. Murphy,J. Xu,and B. Tejada-Vera. “Deaths:Final Data for 2014”. National Vital Statistics Reports 65,no.4 (2016):1-122. [89]Kolata,G. Flu:The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus That Caused It. New York:Touchstone,2005. [90]Lamb,F.,and E. Brannin. “The Epidemic Respiratory Infection at Camp Cody N.M”. JAMA 72,no.15 (1919):1056-62. [91]Langford,C. “Did the 1918-19 Influenza Pandemic Originate in China?” Populationand Development Review 31,no.3 (2005):479-505. [92]Langmuir,A. D.,T. D. Worthen,J. Solomon,C. G. Ray,and E. Petersen. “TheThucydides Syndrome. A New Hypothesis for the Cause of the Plague of Athens”. New England Journal of Medicine 313,no.16 (1985):1027-30. [93]Lazer,D.,R. Kennedy,G. King,and A. Vespignani. “The Parable of Google Flu:Traps in Big Data Analysis”. Science 343,no.6176 (2014):1203-5. [94]Leary,T. “The Use of the Influenza Vaccine in the Present Epidemic”. American Journal of Public Health 8,no.10 (1918):754-55. [95]Li,W.,S. K. Wong,F. Li,J. H. Kuhn,I. C. Huang,H. Choe,and M. Farzan. “Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus:Insight from ACE2-S-Protein Interactions”. Journal of Virology 80,no.9 (2006):4211-19. [96]Linder,J. A. “Vitamin D and the Cure for the Common Cold”. JAMA 308,no.13 (2012):1375-76. [97]Lowen,A. C.,S. Mubareka,J. Steel,and P. Palese. “Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature”. PLoS Pathogens 3,no.10 (2007):1470-76. [98]Malik,M. T.,A. Gumel,L. H. Thompson,T. Strome,and S. M. Mahmud. “‘Google Flu Trends’ and Emergency Department Triage Data Predicted the 2009 Pandemic H1N1 Waves in Manitoba”. Canadian Journal of Public Health 102,no.4 (2011):294-97. [99]Mamelund,S. E. “A Socially Neutral Disease?Individual Social Class,Household Wealth and Mortality from Spanish Influenza in Two Socially ContrastingParishes in Kristiania 1918-19”. Social Science & Medicine 62,no.4 (2006):923-40. [100]McCarthy,M. L.,S. L. Zeger,R. Ding,D. Aronsky,N. R. Hoot,and G. D. Kelen. “The Challenge of Predicting Demand for Emergency Department Services”. Academic Emergency Medicine 15,no.4 (2008):337-46. [101]McGuire,A.,M. Drummond,and S. Keeping. “Childhood and Adolescent Influenza Vaccination in Europe:A Review of Current Policies and Recommendations for the Future”. Expert Review of Vaccines 15,no.5 (2016):659-70. [102]McOscar,J. “Influenza in the Lay Press”. British Medical Journal 2,no.3019 (1918):534. [103]Mitton,S. Fred Hoyle:A Life in Science. Cambridge:Cambridge University Press,2011. [104]Molinari,N. A.,I. R. Ortega-Sanchez,M. L. Messonnier,W. W. Thompson,P. M.Wortley,E. Weintraub,and C. B. Bridges. “The Annual Impact of Seasonal Influenza in the U.S.:Measuring Disease Burden and Costs”. Vaccine 25,no.27 (2007):5086-96. [105]Morens,D. M. “Death of a President”. New England Journal of Medicine 341,no.24 (1999):1845-49. [106]Morens,D. M.,and A. S. Fauci. “The 1918 Influenza Pandemic:Insights for the 21st Century”. Journal of Infectious Disease 195,no.7 (2007):1019-28. [107]Morens,D. M.,G. K. Folkers,and A. S. Fauci. “What Is a Pandemic?” Journal of Infectious Disease 200,no.7 (2009):1018-21. [108]Morens,D. M.,J. K. Taubenberger,and A. S. Fauci. “The Persistent Legacy of the 1918 Influenza Virus”. New England Journal of Medicine 361,no.3 (2009):225-29. [109]Moscona,A. “Neuraminidase Inhibitors for Influenza”. New England Journal of Medicine 353,no.13 (2005):1363-73. [110]Moser,M. R.,T. R. Bender,H. S. Margolis,G. R. Noble,A. P. Kendal,and D. G.Ritter. “An Outbreak of Influenza aboard a Commercial Airliner”. American Journal of Epidemiology 110,no.1 (1979):1-6. [111]Murdoch,D. R.,S. Slow,S. T. Chambers,L. C. Jennings,A. W. Stewart,P. C.Priest,C. M. Florkowski,J. H. Livesey,A. C. Camargo,and R. Scragg. “Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infectionsin Healthy Adults:The Vidaris Randomized Controlled Trial”. JAMA 308,no.13 (2012):1333-39. [112]Murray,C. J.,A. D. Lopez,B. Chin,D. Feehan,and K. H. Hill. “Estimation of Potential Global Pandemic Influenza Mortality on the Basis of Vital Registry Data from the 1918-20 Pandemic:A Quantitative Analysis”. Lancet 368,no.9554 (2006):2211-18. [113]Murthy,S.,and H. Wunsch. “Clinical Review:International Comparisons in Critical Care—Lessons Learned”. Critical Care 16,no.2 (2012):218. [114]Nguyen,J. L.,J. Schwartz,and D. W. Dockery. “The Relationship between Indoor and Outdoor Temperature,Apparent Temperature,Relative Humidity,and Absolute Humidity”. Indoor Air 24,no.1 (2014):103-12. [115]Nicolson,J. The Great Silence,1918-1920:Living in the Shadow of the Great War.London:Grove Press,2010. [116]Noti,J. D.,F. M. Blachere,C. M. McMillen,W. G. Lindsley,M. L. Kashon,D. R.Slaughter,and D. H. Beezhold. “High Humidity Leads to Loss of Infectious Influenza Virus from Simulated Coughs”. PLoS One 8,no.2 (2013):e57485. [117]Olitsky,P.,and F. Gates. “Experimental Study of the Nasopharyngeal Secretions from Influenza Patients”. JAMA 74,no.22 (1920):1497-99. [118]Opie,E.,A. Freeman,F. Blake,J. Small,and T. Rivers. “Pneumonia at Camp Funston”. JAMA 72,no.2 (1919):108-13. [119]Ortiz,J. R.,L. Kamimoto,R. E. Aubert,J. Yao,D. K. Shay,J. S. Bresee,and R. S.Epstein. “Oseltamivir Prescribing in Pharmacy-Benefits Database,United States,2004-2005”. Emerging Infectious Diseases 14,no.8 (2008):1280-83. [120]Oshinsky,D. M. Polio:An American Story. Oxford:Oxford University Press,2005. [121]Oxford,J. S. “The So-Called Great Spanish Influenza Pandemic of 1918 May Have Originated in France in 1916”. Philosophical Transactions of the Royal Society of London,Series B:Biological Sciences 356,no.1416 (2001):1857-59. [122]Patterson,K. D. Pandemic Influenza,1700-1900. Totowa,NJ:Rowman and Littlefield,1986. [123]Patwardhan,A.,and R. Bilkovski. “Comparison:Flu Prescription Sales Data from a Retail Pharmacy in the U.S. with Google Flu Trends and U.S. ILINet (CDC)Data as Flu Activity Indicator”. PLoS One 7,no.8 (2012):e43611. [124]Petersen,W. F.,and S. A. Levinson. “The Therapeutic Effect of Venesection with Reference to Lobar Pneumonia”. JAMA 78,no.4 (1922):257-58. [125]Polgreen,P. M.,F. D. Nelson,and G. R. Neumann. “Use of Prediction Markets to Forecast Infectious Disease Activity”. Clinical Infectious Diseases 44,no.2 (2007):272-79. [126]Prager,F.,D. Wei,and A. Rose. “Total Economic Consequences of an Influenza Outbreak in the United States”. Risk Analysis 37,no.1 (2017):4-19. [127]Price,G. M. “Influenza—Destroyer and Teacher”. Survey 41,no.12 (1918):367-69. [128]“Proceedings of the Forty-Sixth Annual Meeting of the American Public Health Association”. American Journal of Public Health 9,no.2 (1919):130-42. [129]Reichert,T. A.,N. Sugaya,D. S. Fedson,W. P. Glezen,L. Simonsen,and M. Tashiro. “The Japanese Experience with Vaccinating Schoolchildren against Influenza”. New England Journal of Medicine 344,no.12 (2001):889-96. [130]Reid,A. H.,T. A. Janczewski,R. M. Lourens,A. J. Elliot,R. S. Daniels,C. L. Berry,J. S. Oxford,and J. K. Taubenberger. “1918 Influenza Pandemic Caused by Highly Conserved Viruses with Two Receptor-Binding Variants”. Emerging Infectious Diseases 9,no.10 (2003):1249-53. [131]Rice,E. W.,N. J. Adcock,M. Sivaganesan,J. D. Brown,D. E. Stallknecht,and D. E.Swayne. “Chlorine Inactivation of Highly Pathogenic Avian Influenza Virus (H5N1)”. Emerging Infectious Diseases 13,no.10 (2007):1568-70. [132]Riedel,S. “Edward Jenner and the History of Smallpox and Vaccination.” Proceedings (Baylor University Medical Center) 18,no.1 (2005):21-25. [133]Robins,N. S. Copeland’s Cure:Homeopathy and the War between Conventional and Alternative Medicine. New York:Knopf,2005. [134]Rose,A.,G. Oladosu,and S. Liao. “Business Interruption Impacts of a Terrorist Attack on the Electric Power System of Los Angeles:Customer Resilience to a Total Blackout”. Risk Analysis 27,no.3 (2009):513-31. [135]Rosenow,E. “Prophylactic Inoculation against Respiratory Infections”. JAMA 72,no.1 (1919):31-34 [136]Ross,R. S. “A Parlous State of Storm and Stress. The Life and Times of James B.Herrick”. Circulation 67,no.5 (1983):955-59. [137]Saketkhoo,K.,A. Januszkiewicz,and M. A. Sackner. “Effects of Drinking Hot Water,Cold Water,and Chicken Soup on Nasal Mucus Velocity and NasalAirflow Resistance”. Chest 74,no.4 (1978):408-10. [138]Saunders-Hastings,P. R.,and D. Krewski. “Reviewing the History of Pandemic Influenza:Understanding Patterns of Emergence and Transmission”. Pathogens 5,no.4 (2016):66. [139]Sencer,D. J.,and J. D. Millar. “Reflections on the 1976 Swine Flu Vaccination Program”. Emerging Infectious Diseases 12,no.1 (2006):29-33. [140]Shadrin,A. S.,I. G. Marinich,and L. Y. Taros. “Experimental and Epidemiological Estimation of Seasonal and Climato-Geographical Features of Non-Specific Resistance of the Organism to Influenza”. Journal of Hygiene,Epidemiology,Microbiology,and Immunology 21,no.2 (1977):155-61. [141]Shaman,J.,and A. Karspeck. “Forecasting Seasonal Outbreaks of Influenza”. Proceedings of the National Academy of Sciences 109,no.50 (2012):20425-30. [142]Shaman,J.,A. Karspeck,W. Yang,J. Tamerius,and M. Lipsitch. “Real-Time Influenza Forecasts during the 2012-2013 Season”. Nature Communications 4 (2013):2837. [143]Shanks,G. D.,S. Burroughs,J. D. Sohn,N. C. Waters,V. F. Smith,M. Waller,and J. F. Brundage. “Variable Mortality from the 1918-1919 Influenza Pandemic during Military Training”. Military Medicine 181,no.8 (2016):878-82. [144]Sherertz,R. J.,and H. J. Sherertz. “Influenza in the Preantibiotic Era”. Infectious Diseases in Clinical Practice 14,no.3 (2006):127. [145]Shortridge,K. F. “The 1918 ‘Spanish’ Flu:Pearls from Swine?” Nature Medicine 5,no.4 (1999):384-85. [146]Shrestha,S. S.,D. L. Swerdlow,R. H. Borse,V. S. Prabhu,L. Finelli,C. Y. Atkins,K. Owusu-Edusei et al. “Estimating the Burden of 2009 Pandemic Influenza A (H1N1)in the United States (April 2009-April 2010)”. Clinical Infectious Diseases 52,suppl.1 (2011):S75-82. [147]Shufflebotham,F. “Influenza among Poison Gas Workers”. British Medical Journal 1,no.3042 (1919):478-79. [148]Skowronski,D. M.,C. Chambers,G. De Serres,J. A. Dickinson,A. L. Winter,R. Hickman,T. Chan et al. “Early Season Co-circulation of Influenza A (H3N2)and B (Yamagata):Interim Estimates of 2017/18 Vaccine Effectiveness,Canada,January 2018”. Eurosurveillance 23,no.5 (2018):DOI:10.3201/eid1201.051254. [149]Smith,D. C. “Quinine and Fever:The Development of the Effective Dosage”. Journal of the History of Medicine and Allied Sciences 31,no.3 (1976):343-67. [150]Smith,D. W.,and B. S. Bradshaw. “Variation in Life Expectancy during the Twentieth Century in the United States”. Demography 43,no.4 (2006):647-57. [151]Smith,W.,C. Andrewes,and P. Laidlaw. “A Virus Obtained from Influenza Patients”. Lancet 2,no.5723 (1933):66-68. [152]Sneader,W. Drug Discovery:A History. Hoboken,NJ:Wiley & Sons,2005. [153]Sorbello,A.,S. C. Jones,W. Carter,K. Struble,R. Boucher,M. Truffa,D. Birnkrant et al. “Emergency Use Authorization for Intravenous Peramivir:Evaluation of Safety in the Treatment of Hospitalized Patients Infected with 2009 H1N1 Influenza A Virus”. Clinical Infectious Diseases 55,no.1 (2012):1-7. [154]Spurgeon,D. “Roche Canada Stops Distributing Oseltamivir”. British Medical Journal 331,no.7524 (2005):1041. [155]Starko,K. M. “Salicylates and Pandemic Influenza Mortality,1918-1919:Pharmacology,Pathology,and Historic Evidence”. Clinical Infectious Diseases 49,no.9 (2009):1405-10. [156]Stern,H. Theory and Practice of Bloodletting. New York:Rebman Company,1915. [157]Stoecker,C.,N. Sanders,and A. Barreca. “Success Is Something to Sneeze At:Influenza Mortality in Regions That Send Teams to the Super Bowl”. Tulane Economics Working Paper Series 2015;Working Paper 1501. [158]Sydenstricker,E. “The Incidence of Influenza among Persons of Different Economic Status during the Epidemic of 1918”. Public Health Reports 46,no.4 (1931):154-70. [159]Taubenberger,J. K. “The Origin and Virulence of the 1918 ‘Spanish’ InfluenzaVirus”. Proceedings of the American Philosophical Society 150,no.1 (2006):86-112. [160]Taubenberger,J. K.,J. V. Hultin,and D. M. Morens. “Discovery and Characterization of the 1918 Pandemic Influenza Virus in Historical Context”. Antiviral Therapy 12,no.4,part B (2007):581-91. [161]Taubenberger,J. K.,A. H. Reid,and T. G. Fanning. “Capturing a Killer Flu Virus.” Scientific American 292,no.1 (January 2005):62-71. [162]Taubenberger,J. K.,A. H. Reid,A. E. Krafft,K. E. Bijwaard,and T. G. Fanning. “Initial Genetic Characterization of the 1918 ‘Spanish’ Influenza Virus”. Science 275,no.5307 (1997):1793-96. [163]Taubenberger,J. K.,A. H. Reid,R. M. Lourens,R. Wang,G. Jin,and T. G. Fanning. “Characterization of the 1918 Influenza Virus Polymerase Genes”. Nature 437,no.7060 (2005):889-93. [164]Thompson,W. W.,D. K. Shay,E. Weintraub,L. Brammer,N. Cox,L. J. Anderson,and K. Fukuda. “Mortality Associated with Influenza and Respiratory Syncytial Virus in the United States”. JAMA 289,no.2 (2003):179-86. [165]Tiwari,Y.,S. Goel,and A. Singh. “Arrival Time Pattern and Waiting Time Distribution of Patients in the Emergency Outpatient Department of a Tertiary Level Health Care Institution of North India”. Journal of Emergencies,Trauma,and Shock 7,no.3 (2014):160-65. [166]Tumpey,T. M.,C. F. Basler,P. V. Aguilar,H. Zeng,A. Solorzano,D. E. Swayne,N. J. Cox et al. “Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus”. Science 310,no.5745 (2005):77-80. [167]“Undetermined Disease—Valencia”. Public Health Reports 33,no.26 (1918):1087. [168]Urashima,M.,T. Segawa,M. Okazaki,M. Kurihara,Y. Wada,and H. Ida. “Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza A in Schoolchildren”. American Journal of Clinical Nutrition 91,no.5 (2010):1255-60. [169]Valdivia,A.,J. Lopez-Alcalde,M. Vicente,M. Pichiule,M. Ruiz,and M. Ordobas. “Monitoring Influenza Activity in Europe with Google Flu Trends:Comparison with the Findings of Sentinel Physician Networks—Results for 2009-10”. Eurosurveillance 15,no.29 (2010):ii:19621. [170]Vaughan,V. C. Doctor’s Memories. New York:Bobbs-Merrill Company,1926. [171]Von Alvensleben,A. “Influenza According to Hoyle”. Nature 344,no.6265 (1990):374. [172]Watanabe,T.,G. Zhong,C. A. Russell,N. Nakajima,M. Hatta,A. Hanson,R.McBride,et al. “Circulating Avian Influenza Viruses Closely Related to the 1918 Virus Have Pandemic Potential”. Cell Host & Microbe 15,no.6 (2014):692-705. [173]Welch,S. J.,S. S. Jones,and T. Allen. “Mapping the 24-Hour Emergency Department Cycle to Improve Patient Flow”. Joint Commission Journal on Qualityand Patient Safety 33,no.5 (2007):247-55. [174]Welsch,R. A Treasury of Nebraska Pioneer Folklore. Lincoln:University of Nebraska Press,1967. [175]Winternitz,M. C.,I. M. Wason,and F. P. McNamara. The Pathology of Influenza. New Haven,CT:Yale University Press,1920. [176]Wootton,D. Bad Medicine:Doctors Doing Harm since Hippocrates. Oxford:Oxford University Press,2006. [177]Yamanouchi,T.,K. Sakakami,and S. Iwashima. “The Infecting Agent in Influenza:An Experimental Research”. Lancet 193,no.4997 (1919):971. [178]Yang,Y.,A. V. Diez Roux,and C. R. Bingham. “Variability and Seasonality of Active Transportation in USA:Evidence from the 2001 NHTS”. International Journal of Behavioral Nutrition and Physical Activity 8 (2011):96. [179]Zadshir,A.,N. Tareen,D. Pan,K. Norris,and D. Martins. “The Prevalence of Hypovitaminosis D among U.S. Adults:Data from the NHANES III”. Ethnicity & Disease 15,no.4,suppl.5 (2005):S5-97-101. [180]Zhang,X.,M. I. Meltzer,and P. M. Wortley. “FluSurge——a Tool to Estimate Demand for Hospital Services during the Next Pandemic Influenza”. Medical Decision Making 26,no.6 (2006):617-23. [181]Abhimanyu and A. K. Coussens. “The Role of UV Radiation and Vitamin D in the Seasonality and Outcomes of Infectious Disease”. Photochemical and Photobiological Sciences 16,no.3 (2017):314-38. [182]Adams,F. The Genuine Works of Hippocrates. New York:William Wood,1886. [183]Aimone,F. “The 1918 Influenza Epidemic in New York City:A Review of the Public Health Response”. Public Health Reports 125,suppl.3 (2010):71-79. [184]Almond,D. “Is the 1918 Influenza Pandemic Over?Long-Term Effects of InUtero Influenza Exposure in the Post-1940 U.S. Population”. Journal of Political Economy 114,no.41 (2006):672-712. [185]Andrews,C. The Common Cold. New York:W. W. Norton,1965. [186]Barry,J. M. The Great Influenza:The Epic Story of the Deadliest Plague in History. New York:Penguin,2005. [187]Barry,J. M. “The Site of Origin of the 1918 Influenza Pandemic and Its Public Health Implications”. Journal of Translational Medicine 2,no.1 (2004):3. [188]Bergman,P.,A. U. Lindh,L. Bjorkhem-Bergman,and J. D. Lindh. “Vitamin Dand Respiratory Tract Infections:A Systematic Review and Meta-analysis of Randomized Controlled Trials”. PLoS One 8,no.6 (2013):e65835. [189]Blair,G. The Trumps:Three Generations That Built an Empire. New York:Touchstone,2000. [190]Boland,M. E.,S. M. Roper,and J. A. Henry. “Complications of Quinine Poisoning”. Lancet 325,no.8425 (1985):384-85. [191]Brett,A. S.,and A. Zuger.,“The Run on Tamiflu—Should Physicians Prescribeon Demand?” New England Journal of Medicine 353,no.25 (2005):2636-37. [192]Bridges,C. B.,W. W. Thompson,M. I. Meltzer,G. R. Reeve,W. J. Talamonti,N. J. Cox,H. A. Lilac,H. Hall,A. Klimov,and K. Fukuda. “Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults:A Randomized Controlled Trial”. JAMA 284,no.13 (2000):1655-63. [193]Brownstein,J. S.,C. J. Wolfe,and K. D. Mandl.,“Empirical Evidence for the Effect of Airline Travel on Inter-regional Influenza Spread in the United States”. PLoS Medicine 3,no.10 (2006):e401. [194]Butler,D.,“When Google Got Flu Wrong”. Nature 494,no.7436 (2013):155-56. [195]Byerly,C.,Fever of War:The Influenza Epidemic in the U.S. Army during WorldWar I. New York:New York University Press,2005. [196]Cannell,J. J.,R. Vieth,J. C. Umhau,M. F. Holick,W. B. Grant,S. Madronich,C. F.,Garland,and E. Giovannucci. “Epidemic Influenza and Vitamin D”. Epidemiology & Infection 134,no.6 (2006):1129-40. [197]Cello,J.,A. V. Paul,and E. Wimmer. “Chemical Synthesis of Poliovirus cDNA:Generation of Infectious Virus in the Absence of Natural Template”. Science297,no.5583 (2002):1016-18. [198]Centers for Disease Control and Prevention. “Update:Drug Susceptibility of Swine-Origin Influenza A (H1N1)Viruses,April 2009”. Morbidity and Mortality Weekly Report 58,no.16 (2009):433-35. [199]Chartrand,C.,M. M. Leeflang,J. Minion,T. Brewer,and M. Pai. “Accuracy of Rapid Influenza Diagnostic Tests:A Meta-analysis”. Annals of Internal Medicine 156,no.7 (2006):500-11. [200]Collier,R. The Plague of the Spanish Lady:The Influenza Pandemic of 1918-1919. London:Macmillan,1974. [201]Cook,S.,C. Conrad,A. L. Fowlkes,and M. H. Mohebbi. “Assessing Google FluTrends Performance in the United States during the 2009 Influenza Virus A (H1N1)Pandemic”. PLoS One 6,no.8 (2011):e23610. [202]Cooper Cole,C. E. “Preliminary Report on Influenza Epidemic at Bramshott inSeptember-October,1918”. British Medical Journal 2,no.3021 (1918):566-68. [203]Creighton,C. A History of Epidemics in Britain. New York:Barnes & Noble,1965. [204]Crosby,A. W. America’s Forgotten Pandemic:The Influenza of 1918. Cambridge:Cambridge University Press,2003. [205]Das,D.,K. Mertzger,R. Heffernan,S. Balter,D. Weiss,and F. Mostashari. “Monitoring Over-the-Counter Medication Sales for Early Detection of Disease Outbreaks—New York City”. MMWR Supplements 54 (2005):41-46. [206]Debauche,L. Reel Patriotism:The Movies and World War I. Madison:Universityof Wisconsin Press,1997. [207]Demicheli,V.,T. Jefferson,L. A. Al-Ansary,E. Ferroni,and C. Di Pietrantonj. “Vaccines for Preventing Influenza in Healthy Adults”. Cochrane Database of Systematic Reviews 3 (2014):CD001269. [208]Dobson,J.,R. J. Whitley,S. Pocock,and A. S. Monto. “Oseltamivir Treatment for Influenza in Adults:A Meta-analysis of Randomised Controlled Trials”. Lancet 385,no.9979 (2015):1729-37. [209]Doshi,P. “The Elusive Definition of Pandemic Influenza”. Bulletin of the World Health Organization 89 no.7 (2011):532-38. [210]Doshi,P. “The 2009 Influenza Pandemic”. Lancet Infectious Diseases 13,no.3 (2013):193. [211]Dow,K.,and S. Cutter. “Crying Wolf:Repeat Responses to Hurricane EvacuationOrders”. Coastal Management 26,no.4 (1998):237-52. [212]Duncan,K. Hunting the 1918 Flu:One Scientist’s Search for a Killer Virus. Toronto:University of Toronto Press,2003. [213]Earn,D. J.,P. W. Andrews,and B. M. Bolker. “Population-Level Effects of Suppressing Fever”. Proceedings of the Royal Society B:Biological Sciences 281,no.1778 (2014):20132570. [214]Edmond,J. D.,R. G. Johnston,D. Kidd,H. J. Rylance,and R. G. Sommerville. “The Inhibition of Neuraminidase and Antiviral Action”. British Journal of Pharmacology and Chemotherapy 27,no.2 (1966):415-26. [215]Emerman,M.,and H. S. Malik. “Paleovirology—Modern Consequences of AncientViruses”. PLoS Biology 8,no.2 (2010):e1000301. [216]Emerman,M.,and H. S. Malik. “The Epidemic of Influenza”. JAMA 71,no.13 (1918):1063-64. [217]Evans,S. S.,E. A. Repasky,and D. T. Fisher. “Fever and the Thermal Regulation of Immunity:The Immune System Feels the Heat”. Nature Reviews Immunology 15,no.6 (2015):335-49. [218]Eyler,J. M. “The State of Science,Microbiology,and Vaccines circa 1918”. Public Health Reports 125,suppl.3 (2010):27-36. [219]Fabier,F. “Traitement de la Grippe par les Injections de Quinine”. Journal de Médecineet de Chirurgie Pratiques 90 (1919):783-84. [220]Fiore,A. E.,T. M. Uyeki,K. Broder,L. Finelli,G. L. Euler,J. A. Singleton,J. K. Iskander et al. “Prevention and Control of Influenza with Vaccines:Recommendations of the Advisory Committee on Immunization Practices (ACIP),2010”. MMWR Recommendations and Reports 59,no. RR-8 (2010):1-62. [221]Garrett,T. “Pandemic Economics:The 1918 Influenza and Its Modern-Day Implications”. Federal Reserve Bank of St. Louis Review 90,no.2 (2008):75-93. [222]Garrett,T. “War and Pestilence as Labor Market Shocks:U.S. Manufacturing WageGrowth 1914-1919”. Economic Inquiry 47,no.4 (2009):711-25. [223]Gaydos,J. C.,F. H. Top Jr.,R. A. Hodder,and P. K. Russell. “Swine Influenza AOutbreak,Fort Dix,New Jersey,1976”. Emerging Infectious Diseases 12,no.1 (2006):23-28. [224]Gerdil,C. “The Annual Production Cycle for Influenza Vaccine”. Vaccine 21,no.16 (2003):1776-79. [225]Glatstein,M.,and D. Scolnik. “Fever:To Treat or Not to Treat?” World Journal of Pediatrics 4,no.4 (2008):245-47. [226]Godlee,F. “Conflicts of Interest and Pandemic Flu”. British Medical Journal 340 (2010):c2947. [227]Gregor,A. “A Note on the Epidemiology of Influenza among Workers”. British Medical Journal 1,no.3035 (1919):242-43. [228]Grijalva,C. G.,J. P. Nuorti,and M. R. Griffin. “Antibiotic Prescription Rates for Acute Respiratory Tract Infections in U.S. Ambulatory Settings”. JAMA 302,no.7 (2009):758-66. [229]Grist,N. R. “Pandemic Influenza 1918”. British Medical Journal 2,no.6205 (1979):1632-33. [230]Gross,C. P.,and K. A. Sepkowitz. “The Myth of the Medical Break through:Small pox,Vaccination,and Jenner Reconsidered”. International Journal of Infectious Disease 3,no.1 (1998):54-60. [231]Hammond,G. W.,R. L. Raddatz,and D. E. Gelskey. “Impact of Atmospheric Dispersionand Transport of Viral Aerosols on the Epidemiology of Influenza”. Reviews of Infectious Diseases 11,no.3 (1989):494-97. [232]Hammond,J. A. B.,W. Rolland,and T. H. G. Shore. “Purulent Bronchitis:A Studyof Cases Occurring amongst the British Troops at a Base in France”. Lancet 190,no.4898 (1917):41-45. [233]Hannoun,C. “The Evolving History of Influenza Viruses and Influenza Vaccines”. Expert Review of Vaccines 12,no.9 (2013):1085-94. [234]Hawkes,N. “Sharp Spike in Deaths in England and Wales Needs Investigating,Says Public Health Expert”. British Medical Journal 352 (2016):i981. [235]Hayden,F. G.,J. J. Treanor,R. F. Betts,M. Lobo,J. D. Esinhart,and E. K. Hussey. “Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza”. JAMA 275,no.4 (1996):295-99. [236]Henderson,D. A.,B. Courtney,T. V. Inglesby,E. Toner,and J. B. Nuzzo. “Public Health and Medical Responses to the 1957-58 Influenza Pandemic”. Biosecurityand Bioterrorism 7,no.3 (2009):265-73. [237]Herfst,S.,E. J. Schrauwen,M. Linster,S. Chutinimitkul,E. De Wit,V. J. Munster,E. M. Sorrell et al. “Airborne Transmission of Influenza A/H5N1 Virus between Ferrets”. Science 336,no.6088 (2012):1534-41. [238]Hernan,M. A.,and M. Lipsitch. “Oseltamivir and Risk of Lower RespiratoryTract Complications in Patients with Flu Symptoms:A Meta-analysis of Eleven Randomized Clinical Trials”. Clinical Infectious Diseases 53,no.3 (2011):277-79. [239]Herrick,J. B. “Treatment of Influenza by Means Other Than Vaccines and Serums”. JAMA 73,no.7 (1919):482-87. [240]Hiam,L.,D. Dorling,D. Harrison,and M. McKee. “What Caused the Spike in Mortality in England and Wales in January 2015?” Journal of the Royal Society of Medicine 110,no.4 (2017):131-37. [241]Hildreth,M. L. “The Influenza Epidemic of 1918-1919 in France:Contemporary Concepts of Aetiology,Therapy,and Prevention”. Social History of Medicine 4,no.2 (1991):277-94. [242]Hirani,V.,and P. Primatesta. “Vitamin D Concentrations among People Aged 65 Years and Over Living in Private Households and Institutions in England:Population Survey”. Age and Ageing 34 no.5 (2006):485-91. [243]Hirve,S.,L. P. Newman,J. Paget,E. Azziz-Baumgartner,J. Fitzner,N. Bhat,K. Vandemaele,and W. Zhang. “Influenza Seasonality in the Tropics and Subtropics—When to Vaccinate?” PLoS One 11,no.4 (2016):e0153003. [244]Honigsbaum,M. “Regulating the 1918-19 Pandemic:Flu,Stoicism and theNorthcliffe Press”. Medical History 57,no.2 (2013):165-85. [245]Hopkirk,A. F. Influenza:Its History,Nature,Cause and Treatment. New York:Walter Scott Publishing,1914. [246]Hoyle,F.,and C. Wickramasinghe. Evolution from Space:A Theory of Cosmic Creationism.New York:Simon & Schuster,1982. [247]Hoyle,F.,and N. C. Wickramasinghe. “Sunspots and Influenza”. Nature 343,no.6256 (1990):304. [248]Hughes,S. S. The Virus:A History of the Concept. London:Heinemann Educational Books,Science History Publications,1977. [249]Influenza Committee of the Advisory Board to the D.G.M.S.,France. “The Influenza Epidemic in the British Armies in France,1918”. British Medical Journal 2,no.3019 (1918):505-9. [250]“Influenza Discussions”. American Journal of Public Health 9,no.2 (1919):136. [251]“Influenza:Its History,Nature,Cause and Treatment”. Book review. JAMA 63,no.3 (1914):267. [252]“Influenza:Kansas—Haskell”. Public Health Reports 33,no.14 (1918):502. [253]Jack,A. “Flu’s Unexpected Bonus”. British Medical Journal 339 (2009):b3811. “James B. Herrick (1861-1954)”. JAMA 16,no.186 (1963):722-23. [254]Jefferson,T. “Influenza Vaccination:Policy versus Evidence”. British Medical Journal 333,no.7574 (2006):912-15. [255]Jefferson,T.,V. Demicheli,D. Rivetti,M. Jones,C. Di Pietrantonj,and A. Rivetti. “Antivirals for Influenza in Healthy Adults:Systematic Review”. Lancet 367,no.9507 (2006):303-13. [256]Jefferson,T.,and P. Doshi. “Multisystem Failure:The Story of Anti-influenza Drugs”. British Medical Journal 348 (2014):g2263. [257]Jefferson,T.,M. A. Jones,P. Doshi,C. B. Del Mar,R. Hama,M. J. Thompson,E. A. Spencer et al. “Neuraminidase Inhibitors for Preventing and Treating Influenza in Healthy Adults and Children”. Cochrane Database of Systematic Reviews 4 (2014):CD008965. [258]Jenner,E. An Inquiry into the Causes and Effects of the VariolaeVaccinae,a Disease Discovered in Some of the Western Counties of England,Particularly Gloucestershire,and Known by the Name of the Cow Pox. London:Sampson Low,1798. [259]Kaiser,L.,C. Wat,T. Mills,P. Mahoney,P. Ward,and F. Hayden. “Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complicationsand Hospitalizations”. Archives of Internal Medicine 163,no.14 (2003):1667-72. [260]Kamat,S.,V. Maniaci,M. Y. Linares,and J. M. Lozano. “Pediatric Psychiatric Emergency Department Visits during a Full Moon.” Pediatric Emergency Care 30,no.12 (2014):875-78. [261]Kelly,H.,and K. Grant. “Interim Analysis of Pandemic Influenza (H1N1)2009 in Australia:Surveillance Trends,Age of Infection and Effectiveness of SeasonalVaccination”. Eurosurveillance 14,no.31 (2009):1-5. [262]Kennedy,D. “Better Never Than Late”. Science 310,no.5746 (2005):195. [263]Khan,A.,and W. Patrick. The Next Pandemic:On the Front Lines against Humankind’s Gravest Dangers. New York:Public Affairs,2016. [264]Kilbourne,E. D. “Influenza Pandemics of the 20th Century”. Emerging Infectious Diseases 12,no.1 (2006):9-14. [265]Klein,H. A. “The Treatment of ‘Spanish Influenza’”. JAMA 71,no.18 (1918):1510. [266]Kluger,M. J. Fever:Its Biology,Evolution,and Function. Princeton,NJ:Princeton University Press,1979. [267]Kmietowicz,Z. “Use Leftover Tamiflu to Grit Icy Roads,MP Suggests”. British Medical Journal 340 (2010):c501. [268]Kochanek,K. D.,S. L. Murphy,J. Xu,and B. Tejada-Vera. “Deaths:Final Data for 2014”. National Vital Statistics Reports 65,no.4 (2016):1-122. [269]Kolata,G. Flu:The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus That Caused It. New York:Touchstone,2005. [270]Lamb,F.,and E. Brannin. “The Epidemic Respiratory Infection at Camp Cody N.M”. JAMA 72,no.15 (1919):1056-62. [271]Langford,C. “Did the 1918-19 Influenza Pandemic Originate in China?” Populationand Development Review 31,no.3 (2005):479-505. [272]Langmuir,A. D.,T. D. Worthen,J. Solomon,C. G. Ray,and E. Petersen. “TheThucydides Syndrome. A New Hypothesis for the Cause of the Plague of Athens”. New England Journal of Medicine 313,no.16 (1985):1027-30. [273]Lazer,D.,R. Kennedy,G. King,and A. Vespignani. “The Parable of Google Flu:Traps in Big Data Analysis”. Science 343,no.6176 (2014):1203-5. [274]Leary,T. “The Use of the Influenza Vaccine in the Present Epidemic”. American Journal of Public Health 8,no.10 (1918):754-55. [275]Li,W.,S. K. Wong,F. Li,J. H. Kuhn,I. C. Huang,H. Choe,and M. Farzan. “Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus:Insight from ACE2-S-Protein Interactions”. Journal of Virology 80,no.9 (2006):4211-19. [276]Linder,J. A. “Vitamin D and the Cure for the Common Cold”. JAMA 308,no.13 (2012):1375-76. [277]Lowen,A. C.,S. Mubareka,J. Steel,and P. Palese. “Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature”. PLoS Pathogens 3,no.10 (2007):1470-76. [278]Malik,M. T.,A. Gumel,L. H. Thompson,T. Strome,and S. M. Mahmud. “‘Google Flu Trends’ and Emergency Department Triage Data Predicted the 2009 Pandemic H1N1 Waves in Manitoba”. Canadian Journal of Public Health 102,no.4 (2011):294-97. [279]Mamelund,S. E. “A Socially Neutral Disease?Individual Social Class,Household Wealth and Mortality from Spanish Influenza in Two Socially ContrastingParishes in Kristiania 1918-19”. Social Science & Medicine 62,no.4 (2006):923-40. [280]McCarthy,M. L.,S. L. Zeger,R. Ding,D. Aronsky,N. R. Hoot,and G. D. Kelen. “The Challenge of Predicting Demand for Emergency Department Services”. Academic Emergency Medicine 15,no.4 (2008):337-46. [281]McGuire,A.,M. Drummond,and S. Keeping. “Childhood and Adolescent Influenza Vaccination in Europe:A Review of Current Policies and Recommendations for the Future”. Expert Review of Vaccines 15,no.5 (2016):659-70. [282]McOscar,J. “Influenza in the Lay Press”. British Medical Journal 2,no.3019 (1918):534. [283]Mitton,S. Fred Hoyle:A Life in Science. Cambridge:Cambridge University Press,2011. [284]Molinari,N. A.,I. R. Ortega-Sanchez,M. L. Messonnier,W. W. Thompson,P. M.Wortley,E. Weintraub,and C. B. Bridges. “The Annual Impact of Seasonal Influenza in the U.S.:Measuring Disease Burden and Costs”. Vaccine 25,no.27 (2007):5086-96. [285]Morens,D. M. “Death of a President”. New England Journal of Medicine 341,no.24 (1999):1845-49. [286]Morens,D. M.,and A. S. Fauci. “The 1918 Influenza Pandemic:Insights for the 21st Century”. Journal of Infectious Disease 195,no.7 (2007):1019-28. [287]Morens,D. M.,G. K. Folkers,and A. S. Fauci. “What Is a Pandemic?” Journal of Infectious Disease 200,no.7 (2009):1018-21. [288]Morens,D. M.,J. K. Taubenberger,and A. S. Fauci. “The Persistent Legacy of the 1918 Influenza Virus”. New England Journal of Medicine 361,no.3 (2009):225-29. [289]Moscona,A. “Neuraminidase Inhibitors for Influenza”. New England Journal of Medicine 353,no.13 (2005):1363-73. [290]Moser,M. R.,T. R. Bender,H. S. Margolis,G. R. Noble,A. P. Kendal,and D. G.Ritter. “An Outbreak of Influenza aboard a Commercial Airliner”. American Journal of Epidemiology 110,no.1 (1979):1-6. [291]Murdoch,D. R.,S. Slow,S. T. Chambers,L. C. Jennings,A. W. Stewart,P. C.Priest,C. M. Florkowski,J. H. Livesey,A. C. Camargo,and R. Scragg. “Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infectionsin Healthy Adults:The Vidaris Randomized Controlled Trial”. JAMA 308,no.13 (2012):1333-39. [292]Murray,C. J.,A. D. Lopez,B. Chin,D. Feehan,and K. H. Hill. “Estimation of Potential Global Pandemic Influenza Mortality on the Basis of Vital Registry Data from the 1918-20 Pandemic:A Quantitative Analysis”. Lancet 368,no.9554 (2006):2211-18. [293]Murthy,S.,and H. Wunsch. “Clinical Review:International Comparisons in Critical Care—Lessons Learned”. Critical Care 16,no.2 (2012):218. [294]Nguyen,J. L.,J. Schwartz,and D. W. Dockery. “The Relationship between Indoor and Outdoor Temperature,Apparent Temperature,Relative Humidity,and Absolute Humidity”. Indoor Air 24,no.1 (2014):103-12. [295]Nicolson,J. The Great Silence,1918-1920:Living in the Shadow of the Great War.London:Grove Press,2010. [296]Noti,J. D.,F. M. Blachere,C. M. McMillen,W. G. Lindsley,M. L. Kashon,D. R.Slaughter,and D. H. Beezhold. “High Humidity Leads to Loss of Infectious Influenza Virus from Simulated Coughs”. PLoS One 8,no.2 (2013):e57485. [297]Olitsky,P.,and F. Gates. “Experimental Study of the Nasopharyngeal Secretions from Influenza Patients”. JAMA 74,no.22 (1920):1497-99. [298]Opie,E.,A. Freeman,F. Blake,J. Small,and T. Rivers. “Pneumonia at Camp Funston”. JAMA 72,no.2 (1919):108-13. [299]Ortiz,J. R.,L. Kamimoto,R. E. Aubert,J. Yao,D. K. Shay,J. S. Bresee,and R. S.Epstein. “Oseltamivir Prescribing in Pharmacy-Benefits Database,United States,2004-2005”. Emerging Infectious Diseases 14,no.8 (2008):1280-83. [300]Oshinsky,D. M. Polio:An American Story. Oxford:Oxford University Press,2005. [301]Oxford,J. S. “The So-Called Great Spanish Influenza Pandemic of 1918 May Have Originated in France in 1916”. Philosophical Transactions of the Royal Society of London,Series B:Biological Sciences 356,no.1416 (2001):1857-59. [302]Patterson,K. D. Pandemic Influenza,1700-1900. Totowa,NJ:Rowman and Littlefield,1986. [303]Patwardhan,A.,and R. Bilkovski. “Comparison:Flu Prescription Sales Data from a Retail Pharmacy in the U.S. with Google Flu Trends and U.S. ILINet (CDC)Data as Flu Activity Indicator”. PLoS One 7,no.8 (2012):e43611. [304]Petersen,W. F.,and S. A. Levinson. “The Therapeutic Effect of Venesection with Reference to Lobar Pneumonia”. JAMA 78,no.4 (1922):257-58. [305]Polgreen,P. M.,F. D. Nelson,and G. R. Neumann. “Use of Prediction Markets to Forecast Infectious Disease Activity”. Clinical Infectious Diseases 44,no.2 (2007):272-79. [306]Prager,F.,D. Wei,and A. Rose. “Total Economic Consequences of an Influenza Outbreak in the United States”. Risk Analysis 37,no.1 (2017):4-19. [307]Price,G. M. “Influenza—Destroyer and Teacher”. Survey 41,no.12 (1918):367-69. [308]“Proceedings of the Forty-Sixth Annual Meeting of the American Public Health Association”. American Journal of Public Health 9,no.2 (1919):130-42. [309]Reichert,T. A.,N. Sugaya,D. S. Fedson,W. P. Glezen,L. Simonsen,and M. Tashiro. “The Japanese Experience with Vaccinating Schoolchildren against Influenza”. New England Journal of Medicine 344,no.12 (2001):889-96. [310]Reid,A. H.,T. A. Janczewski,R. M. Lourens,A. J. Elliot,R. S. Daniels,C. L. Berry,J. S. Oxford,and J. K. Taubenberger. “1918 Influenza Pandemic Caused by Highly Conserved Viruses with Two Receptor-Binding Variants”. Emerging Infectious Diseases 9,no.10 (2003):1249-53. [311]Rice,E. W.,N. J. Adcock,M. Sivaganesan,J. D. Brown,D. E. Stallknecht,and D. E.Swayne. “Chlorine Inactivation of Highly Pathogenic Avian Influenza Virus (H5N1)”. Emerging Infectious Diseases 13,no.10 (2007):1568-70. [312]Riedel,S. “Edward Jenner and the History of Smallpox and Vaccination.” Proceedings (Baylor University Medical Center) 18,no.1 (2005):21-25. [313]Robins,N. S. Copeland’s Cure:Homeopathy and the War between Conventional and Alternative Medicine. New York:Knopf,2005. [314]Rose,A.,G. Oladosu,and S. Liao. “Business Interruption Impacts of a Terrorist Attack on the Electric Power System of Los Angeles:Customer Resilience to a Total Blackout”. Risk Analysis 27,no.3 (2009):513-31. [315]Rosenow,E. “Prophylactic Inoculation against Respiratory Infections”. JAMA 72,no.1 (1919):31-34 [316]Ross,R. S. “A Parlous State of Storm and Stress. The Life and Times of James B.Herrick”. Circulation 67,no.5 (1983):955-59. [317]Saketkhoo,K.,A. Januszkiewicz,and M. A. Sackner. “Effects of Drinking Hot Water,Cold Water,and Chicken Soup on Nasal Mucus Velocity and NasalAirflow Resistance”. Chest 74,no.4 (1978):408-10. [318]Saunders-Hastings,P. R.,and D. Krewski. “Reviewing the History of Pandemic Influenza:Understanding Patterns of Emergence and Transmission”. Pathogens 5,no.4 (2016):66. [319]Sencer,D. J.,and J. D. Millar. “Reflections on the 1976 Swine Flu Vaccination Program”. Emerging Infectious Diseases 12,no.1 (2006):29-33. [320]Shadrin,A. S.,I. G. Marinich,and L. Y. Taros. “Experimental and Epidemiological Estimation of Seasonal and Climato-Geographical Features of Non-Specific Resistance of the Organism to Influenza”. Journal of Hygiene,Epidemiology,Microbiology,and Immunology 21,no.2 (1977):155-61. [321]Shaman,J.,and A. Karspeck. “Forecasting Seasonal Outbreaks of Influenza”. Proceedings of the National Academy of Sciences 109,no.50 (2012):20425-30. [322]Shaman,J.,A. Karspeck,W. Yang,J. Tamerius,and M. Lipsitch. “Real-Time Influenza Forecasts during the 2012-2013 Season”. Nature Communications 4 (2013):2837. [323]Shanks,G. D.,S. Burroughs,J. D. Sohn,N. C. Waters,V. F. Smith,M. Waller,and J. F. Brundage. “Variable Mortality from the 1918-1919 Influenza Pandemic during Military Training”. Military Medicine 181,no.8 (2016):878-82. [324]Sherertz,R. J.,and H. J. Sherertz. “Influenza in the Preantibiotic Era”. Infectious Diseases in Clinical Practice 14,no.3 (2006):127. [325]Shortridge,K. F. “The 1918 ‘Spanish’ Flu:Pearls from Swine?” Nature Medicine 5,no.4 (1999):384-85. [326]Shrestha,S. S.,D. L. Swerdlow,R. H. Borse,V. S. Prabhu,L. Finelli,C. Y. Atkins,K. Owusu-Edusei et al. “Estimating the Burden of 2009 Pandemic Influenza A (H1N1)in the United States (April 2009-April 2010)”. Clinical Infectious Diseases 52,suppl.1 (2011):S75-82. [327]Shufflebotham,F. “Influenza among Poison Gas Workers”. British Medical Journal 1,no.3042 (1919):478-79. [328]Skowronski,D. M.,C. Chambers,G. De Serres,J. A. Dickinson,A. L. Winter,R. Hickman,T. Chan et al. “Early Season Co-circulation of Influenza A (H3N2)and B (Yamagata):Interim Estimates of 2017/18 Vaccine Effectiveness,Canada,January 2018”. Eurosurveillance 23,no.5 (2018):DOI:10.3201/eid1201.051254. [329]Smith,D. C. “Quinine and Fever:The Development of the Effective Dosage”. Journal of the History of Medicine and Allied Sciences 31,no.3 (1976):343-67. [330]Smith,D. W.,and B. S. Bradshaw. “Variation in Life Expectancy during the Twentieth Century in the United States”. Demography 43,no.4 (2006):647-57. [331]Smith,W.,C. Andrewes,and P. Laidlaw. “A Virus Obtained from Influenza Patients”. Lancet 2,no.5723 (1933):66-68. [332]Sneader,W. Drug Discovery:A History. Hoboken,NJ:Wiley & Sons,2005. [333]Sorbello,A.,S. C. Jones,W. Carter,K. Struble,R. Boucher,M. Truffa,D. Birnkrant et al. “Emergency Use Authorization for Intravenous Peramivir:Evaluation of Safety in the Treatment of Hospitalized Patients Infected with 2009 H1N1 Influenza A Virus”. Clinical Infectious Diseases 55,no.1 (2012):1-7. [334]Spurgeon,D. “Roche Canada Stops Distributing Oseltamivir”. British Medical Journal 331,no.7524 (2005):1041. [335]Starko,K. M. “Salicylates and Pandemic Influenza Mortality,1918-1919:Pharmacology,Pathology,and Historic Evidence”. Clinical Infectious Diseases 49,no.9 (2009):1405-10. [336]Stern,H. Theory and Practice of Bloodletting. New York:Rebman Company,1915. [337]Stoecker,C.,N. Sanders,and A. Barreca. “Success Is Something to Sneeze At:Influenza Mortality in Regions That Send Teams to the Super Bowl”. Tulane Economics Working Paper Series 2015;Working Paper 1501. [338]Sydenstricker,E. “The Incidence of Influenza among Persons of Different Economic Status during the Epidemic of 1918”. Public Health Reports 46,no.4 (1931):154-70. [339]Taubenberger,J. K. “The Origin and Virulence of the 1918 ‘Spanish’ InfluenzaVirus”. Proceedings of the American Philosophical Society 150,no.1 (2006):86-112. [340]Taubenberger,J. K.,J. V. Hultin,and D. M. Morens. “Discovery and Characterization of the 1918 Pandemic Influenza Virus in Historical Context”. Antiviral Therapy 12,no.4,part B (2007):581-91. [341]Taubenberger,J. K.,A. H. Reid,and T. G. Fanning. “Capturing a Killer Flu Virus.” Scientific American 292,no.1 (January 2005):62-71. [342]Taubenberger,J. K.,A. H. Reid,A. E. Krafft,K. E. Bijwaard,and T. G. Fanning. “Initial Genetic Characterization of the 1918 ‘Spanish’ Influenza Virus”. Science 275,no.5307 (1997):1793-96. [343]Taubenberger,J. K.,A. H. Reid,R. M. Lourens,R. Wang,G. Jin,and T. G. Fanning. “Characterization of the 1918 Influenza Virus Polymerase Genes”. Nature 437,no.7060 (2005):889-93. [344]Thompson,W. W.,D. K. Shay,E. Weintraub,L. Brammer,N. Cox,L. J. Anderson,and K. Fukuda. “Mortality Associated with Influenza and Respiratory Syncytial Virus in the United States”. JAMA 289,no.2 (2003):179-86. [345]Tiwari,Y.,S. Goel,and A. Singh. “Arrival Time Pattern and Waiting Time Distribution of Patients in the Emergency Outpatient Department of a Tertiary Level Health Care Institution of North India”. Journal of Emergencies,Trauma,and Shock 7,no.3 (2014):160-65. [346]Tumpey,T. M.,C. F. Basler,P. V. Aguilar,H. Zeng,A. Solorzano,D. E. Swayne,N. J. Cox et al. “Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus”. Science 310,no.5745 (2005):77-80. [347]“Undetermined Disease—Valencia”. Public Health Reports 33,no.26 (1918):1087. [348]Urashima,M.,T. Segawa,M. Okazaki,M. Kurihara,Y. Wada,and H. Ida. “Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza A in Schoolchildren”. American Journal of Clinical Nutrition 91,no.5 (2010):1255-60. [349]Valdivia,A.,J. Lopez-Alcalde,M. Vicente,M. Pichiule,M. Ruiz,and M. Ordobas. “Monitoring Influenza Activity in Europe with Google Flu Trends:Comparison with the Findings of Sentinel Physician Networks—Results for 2009-10”. Eurosurveillance 15,no.29 (2010):ii:19621. [350]Vaughan,V. C. Doctor’s Memories. New York:Bobbs-Merrill Company,1926. [351]Von Alvensleben,A. “Influenza According to Hoyle”. Nature 344,no.6265 (1990):374. [352]Watanabe,T.,G. Zhong,C. A. Russell,N. Nakajima,M. Hatta,A. Hanson,R.McBride,et al. “Circulating Avian Influenza Viruses Closely Related to the 1918 Virus Have Pandemic Potential”. Cell Host & Microbe 15,no.6 (2014):692-705. [353]Welch,S. J.,S. S. Jones,and T. Allen. “Mapping the 24-Hour Emergency Department Cycle to Improve Patient Flow”. Joint Commission Journal on Qualityand Patient Safety 33,no.5 (2007):247-55. [354]Welsch,R. A Treasury of Nebraska Pioneer Folklore. Lincoln:University of Nebraska Press,1967. [355]Winternitz,M. C.,I. M. Wason,and F. P. McNamara. The Pathology of Influenza. New Haven,CT:Yale University Press,1920. [356]Wootton,D. Bad Medicine:Doctors Doing Harm since Hippocrates. Oxford:Oxford University Press,2006. [357]Yamanouchi,T.,K. Sakakami,and S. Iwashima. “The Infecting Agent in Influenza:An Experimental Research”. Lancet 193,no.4997 (1919):971. [358]Yang,Y.,A. V. Diez Roux,and C. R. Bingham. “Variability and Seasonality of Active Transportation in USA:Evidence from the 2001 NHTS”. International Journal of Behavioral Nutrition and Physical Activity 8 (2011):96. [359]Zadshir,A.,N. Tareen,D. Pan,K. Norris,and D. Martins. “The Prevalence of Hypovitaminosis D among U.S. Adults:Data from the NHANES III”. Ethnicity & Disease 15,no.4,suppl.5 (2005):S5-97-101. [360]Zhang,X.,M. I. Meltzer,and P. M. Wortley. “FluSurge——a Tool to Estimate Demand for Hospital Services during the Next Pandemic Influenza”. Medical Decision Making 26,no.6 (2006):617-23. [361]Abhimanyu and A. K. Coussens. “The Role of UV Radiation and Vitamin D in the Seasonality and Outcomes of Infectious Disease”. Photochemical and Photobiological Sciences 16,no.3 (2017):314-38. [362]Adams,F. The Genuine Works of Hippocrates. New York:William Wood,1886. [363]Aimone,F. “The 1918 Influenza Epidemic in New York City:A Review of the Public Health Response”. Public Health Reports 125,suppl.3 (2010):71-79. [364]Almond,D. “Is the 1918 Influenza Pandemic Over?Long-Term Effects of InUtero Influenza Exposure in the Post-1940 U.S. Population”. Journal of Political Economy 114,no.41 (2006):672-712. [365]Andrews,C. The Common Cold. New York:W. W. Norton,1965. [366]Barry,J. M. The Great Influenza:The Epic Story of the Deadliest Plague in History. New York:Penguin,2005. [367]Barry,J. M. “The Site of Origin of the 1918 Influenza Pandemic and Its Public Health Implications”. Journal of Translational Medicine 2,no.1 (2004):3. [368]Bergman,P.,A. U. Lindh,L. Bjorkhem-Bergman,and J. D. Lindh. “Vitamin Dand Respiratory Tract Infections:A Systematic Review and Meta-analysis of Randomized Controlled Trials”. PLoS One 8,no.6 (2013):e65835. [369]Blair,G. The Trumps:Three Generations That Built an Empire. New York:Touchstone,2000. [370]Boland,M. E.,S. M. Roper,and J. A. Henry. “Complications of Quinine Poisoning”. Lancet 325,no.8425 (1985):384-85. [371]Brett,A. S.,and A. Zuger.,“The Run on Tamiflu—Should Physicians Prescribeon Demand?” New England Journal of Medicine 353,no.25 (2005):2636-37. [372]Bridges,C. B.,W. W. Thompson,M. I. Meltzer,G. R. Reeve,W. J. Talamonti,N. J. Cox,H. A. Lilac,H. Hall,A. Klimov,and K. Fukuda. “Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults:A Randomized Controlled Trial”. JAMA 284,no.13 (2000):1655-63. [373]Brownstein,J. S.,C. J. Wolfe,and K. D. Mandl.,“Empirical Evidence for the Effect of Airline Travel on Inter-regional Influenza Spread in the United States”. PLoS Medicine 3,no.10 (2006):e401. [374]Butler,D.,“When Google Got Flu Wrong”. Nature 494,no.7436 (2013):155-56. [375]Byerly,C.,Fever of War:The Influenza Epidemic in the U.S. Army during WorldWar I. New York:New York University Press,2005. [376]Cannell,J. J.,R. Vieth,J. C. Umhau,M. F. Holick,W. B. Grant,S. Madronich,C. F.,Garland,and E. Giovannucci. “Epidemic Influenza and Vitamin D”. Epidemiology & Infection 134,no.6 (2006):1129-40. [377]Cello,J.,A. V. Paul,and E. Wimmer. “Chemical Synthesis of Poliovirus cDNA:Generation of Infectious Virus in the Absence of Natural Template”. Science297,no.5583 (2002):1016-18. [378]Centers for Disease Control and Prevention. “Update:Drug Susceptibility of Swine-Origin Influenza A (H1N1)Viruses,April 2009”. Morbidity and Mortality Weekly Report 58,no.16 (2009):433-35. [379]Chartrand,C.,M. M. Leeflang,J. Minion,T. Brewer,and M. Pai. “Accuracy of Rapid Influenza Diagnostic Tests:A Meta-analysis”. Annals of Internal Medicine 156,no.7 (2006):500-11. [380]Collier,R. The Plague of the Spanish Lady:The Influenza Pandemic of 1918-1919. London:Macmillan,1974. [381]Cook,S.,C. Conrad,A. L. Fowlkes,and M. H. Mohebbi. “Assessing Google FluTrends Performance in the United States during the 2009 Influenza Virus A (H1N1)Pandemic”. PLoS One 6,no.8 (2011):e23610. [382]Cooper Cole,C. E. “Preliminary Report on Influenza Epidemic at Bramshott inSeptember-October,1918”. British Medical Journal 2,no.3021 (1918):566-68. [383]Creighton,C. A History of Epidemics in Britain. New York:Barnes & Noble,1965. [384]Crosby,A. W. America’s Forgotten Pandemic:The Influenza of 1918. Cambridge:Cambridge University Press,2003. [385]Das,D.,K. Mertzger,R. Heffernan,S. Balter,D. Weiss,and F. Mostashari. “Monitoring Over-the-Counter Medication Sales for Early Detection of Disease Outbreaks—New York City”. MMWR Supplements 54 (2005):41-46. [386]Debauche,L. Reel Patriotism:The Movies and World War I. Madison:Universityof Wisconsin Press,1997. [387]Demicheli,V.,T. Jefferson,L. A. Al-Ansary,E. Ferroni,and C. Di Pietrantonj. “Vaccines for Preventing Influenza in Healthy Adults”. Cochrane Database of Systematic Reviews 3 (2014):CD001269. [388]Dobson,J.,R. J. Whitley,S. Pocock,and A. S. Monto. “Oseltamivir Treatment for Influenza in Adults:A Meta-analysis of Randomised Controlled Trials”. Lancet 385,no.9979 (2015):1729-37. [389]Doshi,P. “The Elusive Definition of Pandemic Influenza”. Bulletin of the World Health Organization 89 no.7 (2011):532-38. [390]Doshi,P. “The 2009 Influenza Pandemic”. Lancet Infectious Diseases 13,no.3 (2013):193. [391]Dow,K.,and S. Cutter. “Crying Wolf:Repeat Responses to Hurricane EvacuationOrders”. Coastal Management 26,no.4 (1998):237-52. [392]Duncan,K. Hunting the 1918 Flu:One Scientist’s Search for a Killer Virus. Toronto:University of Toronto Press,2003. [393]Earn,D. J.,P. W. Andrews,and B. M. Bolker. “Population-Level Effects of Suppressing Fever”. Proceedings of the Royal Society B:Biological Sciences 281,no.1778 (2014):20132570. [394]Edmond,J. D.,R. G. Johnston,D. Kidd,H. J. Rylance,and R. G. Sommerville. “The Inhibition of Neuraminidase and Antiviral Action”. British Journal of Pharmacology and Chemotherapy 27,no.2 (1966):415-26. [395]Emerman,M.,and H. S. Malik. “Paleovirology—Modern Consequences of AncientViruses”. PLoS Biology 8,no.2 (2010):e1000301. [396]Emerman,M.,and H. S. Malik. “The Epidemic of Influenza”. JAMA 71,no.13 (1918):1063-64. [397]Evans,S. S.,E. A. Repasky,and D. T. Fisher. “Fever and the Thermal Regulation of Immunity:The Immune System Feels the Heat”. Nature Reviews Immunology 15,no.6 (2015):335-49. [398]Eyler,J. M. “The State of Science,Microbiology,and Vaccines circa 1918”. Public Health Reports 125,suppl.3 (2010):27-36. [399]Fabier,F. “Traitement de la Grippe par les Injections de Quinine”. Journal de Médecineet de Chirurgie Pratiques 90 (1919):783-84. [400]Fiore,A. E.,T. M. Uyeki,K. Broder,L. Finelli,G. L. Euler,J. A. Singleton,J. K. Iskander et al. “Prevention and Control of Influenza with Vaccines:Recommendations of the Advisory Committee on Immunization Practices (ACIP),2010”. MMWR Recommendations and Reports 59,no. RR-8 (2010):1-62. [401]Garrett,T. “Pandemic Economics:The 1918 Influenza and Its Modern-Day Implications”. Federal Reserve Bank of St. Louis Review 90,no.2 (2008):75-93. [402]Garrett,T. “War and Pestilence as Labor Market Shocks:U.S. Manufacturing WageGrowth 1914-1919”. Economic Inquiry 47,no.4 (2009):711-25. [403]Gaydos,J. C.,F. H. Top Jr.,R. A. Hodder,and P. K. Russell. “Swine Influenza AOutbreak,Fort Dix,New Jersey,1976”. Emerging Infectious Diseases 12,no.1 (2006):23-28. [404]Gerdil,C. “The Annual Production Cycle for Influenza Vaccine”. Vaccine 21,no.16 (2003):1776-79. [405]Glatstein,M.,and D. Scolnik. “Fever:To Treat or Not to Treat?” World Journal of Pediatrics 4,no.4 (2008):245-47. [406]Godlee,F. “Conflicts of Interest and Pandemic Flu”. British Medical Journal 340 (2010):c2947. [407]Gregor,A. “A Note on the Epidemiology of Influenza among Workers”. British Medical Journal 1,no.3035 (1919):242-43. [408]Grijalva,C. G.,J. P. Nuorti,and M. R. Griffin. “Antibiotic Prescription Rates for Acute Respiratory Tract Infections in U.S. Ambulatory Settings”. JAMA 302,no.7 (2009):758-66. [409]Grist,N. R. “Pandemic Influenza 1918”. British Medical Journal 2,no.6205 (1979):1632-33. [410]Gross,C. P.,and K. A. Sepkowitz. “The Myth of the Medical Break through:Small pox,Vaccination,and Jenner Reconsidered”. International Journal of Infectious Disease 3,no.1 (1998):54-60. [411]Hammond,G. W.,R. L. Raddatz,and D. E. Gelskey. “Impact of Atmospheric Dispersionand Transport of Viral Aerosols on the Epidemiology of Influenza”. Reviews of Infectious Diseases 11,no.3 (1989):494-97. [412]Hammond,J. A. B.,W. Rolland,and T. H. G. Shore. “Purulent Bronchitis:A Studyof Cases Occurring amongst the British Troops at a Base in France”. Lancet 190,no.4898 (1917):41-45. [413]Hannoun,C. “The Evolving History of Influenza Viruses and Influenza Vaccines”. Expert Review of Vaccines 12,no.9 (2013):1085-94. [414]Hawkes,N. “Sharp Spike in Deaths in England and Wales Needs Investigating,Says Public Health Expert”. British Medical Journal 352 (2016):i981. [415]Hayden,F. G.,J. J. Treanor,R. F. Betts,M. Lobo,J. D. Esinhart,and E. K. Hussey. “Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza”. JAMA 275,no.4 (1996):295-99. [416]Henderson,D. A.,B. Courtney,T. V. Inglesby,E. Toner,and J. B. Nuzzo. “Public Health and Medical Responses to the 1957-58 Influenza Pandemic”. Biosecurityand Bioterrorism 7,no.3 (2009):265-73. [417]Herfst,S.,E. J. Schrauwen,M. Linster,S. Chutinimitkul,E. De Wit,V. J. Munster,E. M. Sorrell et al. “Airborne Transmission of Influenza A/H5N1 Virus between Ferrets”. Science 336,no.6088 (2012):1534-41. [418]Hernan,M. A.,and M. Lipsitch. “Oseltamivir and Risk of Lower RespiratoryTract Complications in Patients with Flu Symptoms:A Meta-analysis of Eleven Randomized Clinical Trials”. Clinical Infectious Diseases 53,no.3 (2011):277-79. [419]Herrick,J. B. “Treatment of Influenza by Means Other Than Vaccines and Serums”. JAMA 73,no.7 (1919):482-87. [420]Hiam,L.,D. Dorling,D. Harrison,and M. McKee. “What Caused the Spike in Mortality in England and Wales in January 2015?” Journal of the Royal Society of Medicine 110,no.4 (2017):131-37. [421]Hildreth,M. L. “The Influenza Epidemic of 1918-1919 in France:Contemporary Concepts of Aetiology,Therapy,and Prevention”. Social History of Medicine 4,no.2 (1991):277-94. [422]Hirani,V.,and P. Primatesta. “Vitamin D Concentrations among People Aged 65 Years and Over Living in Private Households and Institutions in England:Population Survey”. Age and Ageing 34 no.5 (2006):485-91. [423]Hirve,S.,L. P. Newman,J. Paget,E. Azziz-Baumgartner,J. Fitzner,N. Bhat,K. Vandemaele,and W. Zhang. “Influenza Seasonality in the Tropics and Subtropics—When to Vaccinate?” PLoS One 11,no.4 (2016):e0153003. [424]Honigsbaum,M. “Regulating the 1918-19 Pandemic:Flu,Stoicism and theNorthcliffe Press”. Medical History 57,no.2 (2013):165-85. [425]Hopkirk,A. F. Influenza:Its History,Nature,Cause and Treatment. New York:Walter Scott Publishing,1914. [426]Hoyle,F.,and C. Wickramasinghe. Evolution from Space:A Theory of Cosmic Creationism.New York:Simon & Schuster,1982. [427]Hoyle,F.,and N. C. Wickramasinghe. “Sunspots and Influenza”. Nature 343,no.6256 (1990):304. [428]Hughes,S. S. The Virus:A History of the Concept. London:Heinemann Educational Books,Science History Publications,1977. [429]Influenza Committee of the Advisory Board to the D.G.M.S.,France. “The Influenza Epidemic in the British Armies in France,1918”. British Medical Journal 2,no.3019 (1918):505-9. [430]“Influenza Discussions”. American Journal of Public Health 9,no.2 (1919):136. [431]“Influenza:Its History,Nature,Cause and Treatment”. Book review. JAMA 63,no.3 (1914):267. [432]“Influenza:Kansas—Haskell”. Public Health Reports 33,no.14 (1918):502. [433]Jack,A. “Flu’s Unexpected Bonus”. British Medical Journal 339 (2009):b3811. “James B. Herrick (1861-1954)”. JAMA 16,no.186 (1963):722-23. [434]Jefferson,T. “Influenza Vaccination:Policy versus Evidence”. British Medical Journal 333,no.7574 (2006):912-15. [435]Jefferson,T.,V. Demicheli,D. Rivetti,M. Jones,C. Di Pietrantonj,and A. Rivetti. “Antivirals for Influenza in Healthy Adults:Systematic Review”. Lancet 367,no.9507 (2006):303-13. [436]Jefferson,T.,and P. Doshi. “Multisystem Failure:The Story of Anti-influenza Drugs”. British Medical Journal 348 (2014):g2263. [437]Jefferson,T.,M. A. Jones,P. Doshi,C. B. Del Mar,R. Hama,M. J. Thompson,E. A. Spencer et al. “Neuraminidase Inhibitors for Preventing and Treating Influenza in Healthy Adults and Children”. Cochrane Database of Systematic Reviews 4 (2014):CD008965. [438]Jenner,E. An Inquiry into the Causes and Effects of the VariolaeVaccinae,a Disease Discovered in Some of the Western Counties of England,Particularly Gloucestershire,and Known by the Name of the Cow Pox. London:Sampson Low,1798. [439]Kaiser,L.,C. Wat,T. Mills,P. Mahoney,P. Ward,and F. Hayden. “Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complicationsand Hospitalizations”. Archives of Internal Medicine 163,no.14 (2003):1667-72. [440]Kamat,S.,V. Maniaci,M. Y. Linares,and J. M. Lozano. “Pediatric Psychiatric Emergency Department Visits during a Full Moon.” Pediatric Emergency Care 30,no.12 (2014):875-78. [441]Kelly,H.,and K. Grant. “Interim Analysis of Pandemic Influenza (H1N1)2009 in Australia:Surveillance Trends,Age of Infection and Effectiveness of SeasonalVaccination”. Eurosurveillance 14,no.31 (2009):1-5. [442]Kennedy,D. “Better Never Than Late”. Science 310,no.5746 (2005):195. [443]Khan,A.,and W. Patrick. The Next Pandemic:On the Front Lines against Humankind’s Gravest Dangers. New York:Public Affairs,2016. [444]Kilbourne,E. D. “Influenza Pandemics of the 20th Century”. Emerging Infectious Diseases 12,no.1 (2006):9-14. [445]Klein,H. A. “The Treatment of ‘Spanish Influenza’”. JAMA 71,no.18 (1918):1510. [446]Kluger,M. J. Fever:Its Biology,Evolution,and Function. Princeton,NJ:Princeton University Press,1979. [447]Kmietowicz,Z. “Use Leftover Tamiflu to Grit Icy Roads,MP Suggests”. British Medical Journal 340 (2010):c501. [448]Kochanek,K. D.,S. L. Murphy,J. Xu,and B. Tejada-Vera. “Deaths:Final Data for 2014”. National Vital Statistics Reports 65,no.4 (2016):1-122. [449]Kolata,G. Flu:The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus That Caused It. New York:Touchstone,2005. [450]Lamb,F.,and E. Brannin. “The Epidemic Respiratory Infection at Camp Cody N.M”. JAMA 72,no.15 (1919):1056-62. [451]Langford,C. “Did the 1918-19 Influenza Pandemic Originate in China?” Populationand Development Review 31,no.3 (2005):479-505. [452]Langmuir,A. D.,T. D. Worthen,J. Solomon,C. G. Ray,and E. Petersen. “TheThucydides Syndrome. A New Hypothesis for the Cause of the Plague of Athens”. New England Journal of Medicine 313,no.16 (1985):1027-30. [453]Lazer,D.,R. Kennedy,G. King,and A. Vespignani. “The Parable of Google Flu:Traps in Big Data Analysis”. Science 343,no.6176 (2014):1203-5. [454]Leary,T. “The Use of the Influenza Vaccine in the Present Epidemic”. American Journal of Public Health 8,no.10 (1918):754-55. [455]Li,W.,S. K. Wong,F. Li,J. H. Kuhn,I. C. Huang,H. Choe,and M. Farzan. “Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus:Insight from ACE2-S-Protein Interactions”. Journal of Virology 80,no.9 (2006):4211-19. [456]Linder,J. A. “Vitamin D and the Cure for the Common Cold”. JAMA 308,no.13 (2012):1375-76. [457]Lowen,A. C.,S. Mubareka,J. Steel,and P. Palese. “Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature”. PLoS Pathogens 3,no.10 (2007):1470-76. [458]Malik,M. T.,A. Gumel,L. H. Thompson,T. Strome,and S. M. Mahmud. “‘Google Flu Trends’ and Emergency Department Triage Data Predicted the 2009 Pandemic H1N1 Waves in Manitoba”. Canadian Journal of Public Health 102,no.4 (2011):294-97. [459]Mamelund,S. E. “A Socially Neutral Disease?Individual Social Class,Household Wealth and Mortality from Spanish Influenza in Two Socially ContrastingParishes in Kristiania 1918-19”. Social Science & Medicine 62,no.4 (2006):923-40. [460]McCarthy,M. L.,S. L. Zeger,R. Ding,D. Aronsky,N. R. Hoot,and G. D. Kelen. “The Challenge of Predicting Demand for Emergency Department Services”. Academic Emergency Medicine 15,no.4 (2008):337-46. [461]McGuire,A.,M. Drummond,and S. Keeping. “Childhood and Adolescent Influenza Vaccination in Europe:A Review of Current Policies and Recommendations for the Future”. Expert Review of Vaccines 15,no.5 (2016):659-70. [462]McOscar,J. “Influenza in the Lay Press”. British Medical Journal 2,no.3019 (1918):534. [463]Mitton,S. Fred Hoyle:A Life in Science. Cambridge:Cambridge University Press,2011. [464]Molinari,N. A.,I. R. Ortega-Sanchez,M. L. Messonnier,W. W. Thompson,P. M.Wortley,E. Weintraub,and C. B. Bridges. “The Annual Impact of Seasonal Influenza in the U.S.:Measuring Disease Burden and Costs”. Vaccine 25,no.27 (2007):5086-96. [465]Morens,D. M. “Death of a President”. New England Journal of Medicine 341,no.24 (1999):1845-49. [466]Morens,D. M.,and A. S. Fauci. “The 1918 Influenza Pandemic:Insights for the 21st Century”. Journal of Infectious Disease 195,no.7 (2007):1019-28. [467]Morens,D. M.,G. K. Folkers,and A. S. Fauci. “What Is a Pandemic?” Journal of Infectious Disease 200,no.7 (2009):1018-21. [468]Morens,D. M.,J. K. Taubenberger,and A. S. Fauci. “The Persistent Legacy of the 1918 Influenza Virus”. New England Journal of Medicine 361,no.3 (2009):225-29. [469]Moscona,A. “Neuraminidase Inhibitors for Influenza”. New England Journal of Medicine 353,no.13 (2005):1363-73. [470]Moser,M. R.,T. R. Bender,H. S. Margolis,G. R. Noble,A. P. Kendal,and D. G.Ritter. “An Outbreak of Influenza aboard a Commercial Airliner”. American Journal of Epidemiology 110,no.1 (1979):1-6. [471]Murdoch,D. R.,S. Slow,S. T. Chambers,L. C. Jennings,A. W. Stewart,P. C.Priest,C. M. Florkowski,J. H. Livesey,A. C. Camargo,and R. Scragg. “Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infectionsin Healthy Adults:The Vidaris Randomized Controlled Trial”. JAMA 308,no.13 (2012):1333-39. [472]Murray,C. J.,A. D. Lopez,B. Chin,D. Feehan,and K. H. Hill. “Estimation of Potential Global Pandemic Influenza Mortality on the Basis of Vital Registry Data from the 1918-20 Pandemic:A Quantitative Analysis”. Lancet 368,no.9554 (2006):2211-18. [473]Murthy,S.,and H. Wunsch. “Clinical Review:International Comparisons in Critical Care—Lessons Learned”. Critical Care 16,no.2 (2012):218. [474]Nguyen,J. L.,J. Schwartz,and D. W. Dockery. “The Relationship between Indoor and Outdoor Temperature,Apparent Temperature,Relative Humidity,and Absolute Humidity”. Indoor Air 24,no.1 (2014):103-12. [475]Nicolson,J. The Great Silence,1918-1920:Living in the Shadow of the Great War.London:Grove Press,2010. [476]Noti,J. D.,F. M. Blachere,C. M. McMillen,W. G. Lindsley,M. L. Kashon,D. R.Slaughter,and D. H. Beezhold. “High Humidity Leads to Loss of Infectious Influenza Virus from Simulated Coughs”. PLoS One 8,no.2 (2013):e57485. [477]Olitsky,P.,and F. Gates. “Experimental Study of the Nasopharyngeal Secretions from Influenza Patients”. JAMA 74,no.22 (1920):1497-99. [478]Opie,E.,A. Freeman,F. Blake,J. Small,and T. Rivers. “Pneumonia at Camp Funston”. JAMA 72,no.2 (1919):108-13. [479]Ortiz,J. R.,L. Kamimoto,R. E. Aubert,J. Yao,D. K. Shay,J. S. Bresee,and R. S.Epstein. “Oseltamivir Prescribing in Pharmacy-Benefits Database,United States,2004-2005”. Emerging Infectious Diseases 14,no.8 (2008):1280-83. [480]Oshinsky,D. M. Polio:An American Story. Oxford:Oxford University Press,2005. [481]Oxford,J. S. “The So-Called Great Spanish Influenza Pandemic of 1918 May Have Originated in France in 1916”. Philosophical Transactions of the Royal Society of London,Series B:Biological Sciences 356,no.1416 (2001):1857-59. [482]Patterson,K. D. Pandemic Influenza,1700-1900. Totowa,NJ:Rowman and Littlefield,1986. [483]Patwardhan,A.,and R. Bilkovski. “Comparison:Flu Prescription Sales Data from a Retail Pharmacy in the U.S. with Google Flu Trends and U.S. ILINet (CDC)Data as Flu Activity Indicator”. PLoS One 7,no.8 (2012):e43611. [484]Petersen,W. F.,and S. A. Levinson. “The Therapeutic Effect of Venesection with Reference to Lobar Pneumonia”. JAMA 78,no.4 (1922):257-58. [485]Polgreen,P. M.,F. D. Nelson,and G. R. Neumann. “Use of Prediction Markets to Forecast Infectious Disease Activity”. Clinical Infectious Diseases 44,no.2 (2007):272-79. [486]Prager,F.,D. Wei,and A. Rose. “Total Economic Consequences of an Influenza Outbreak in the United States”. Risk Analysis 37,no.1 (2017):4-19. [487]Price,G. M. “Influenza—Destroyer and Teacher”. Survey 41,no.12 (1918):367-69. [488]“Proceedings of the Forty-Sixth Annual Meeting of the American Public Health Association”. American Journal of Public Health 9,no.2 (1919):130-42. [489]Reichert,T. A.,N. Sugaya,D. S. Fedson,W. P. Glezen,L. Simonsen,and M. Tashiro. “The Japanese Experience with Vaccinating Schoolchildren against Influenza”. New England Journal of Medicine 344,no.12 (2001):889-96. [490]Reid,A. H.,T. A. Janczewski,R. M. Lourens,A. J. Elliot,R. S. Daniels,C. L. Berry,J. S. Oxford,and J. K. Taubenberger. “1918 Influenza Pandemic Caused by Highly Conserved Viruses with Two Receptor-Binding Variants”. Emerging Infectious Diseases 9,no.10 (2003):1249-53. [491]Rice,E. W.,N. J. Adcock,M. Sivaganesan,J. D. Brown,D. E. Stallknecht,and D. E.Swayne. “Chlorine Inactivation of Highly Pathogenic Avian Influenza Virus (H5N1)”. Emerging Infectious Diseases 13,no.10 (2007):1568-70. [492]Riedel,S. “Edward Jenner and the History of Smallpox and Vaccination.” Proceedings (Baylor University Medical Center) 18,no.1 (2005):21-25. [493]Robins,N. S. Copeland’s Cure:Homeopathy and the War between Conventional and Alternative Medicine. New York:Knopf,2005. [494]Rose,A.,G. Oladosu,and S. Liao. “Business Interruption Impacts of a Terrorist Attack on the Electric Power System of Los Angeles:Customer Resilience to a Total Blackout”. Risk Analysis 27,no.3 (2009):513-31. [495]Rosenow,E. “Prophylactic Inoculation against Respiratory Infections”. JAMA 72,no.1 (1919):31-34 [496]Ross,R. S. “A Parlous State of Storm and Stress. The Life and Times of James B.Herrick”. Circulation 67,no.5 (1983):955-59. [497]Saketkhoo,K.,A. Januszkiewicz,and M. A. Sackner. “Effects of Drinking Hot Water,Cold Water,and Chicken Soup on Nasal Mucus Velocity and NasalAirflow Resistance”. Chest 74,no.4 (1978):408-10. [498]Saunders-Hastings,P. R.,and D. Krewski. “Reviewing the History of Pandemic Influenza:Understanding Patterns of Emergence and Transmission”. Pathogens 5,no.4 (2016):66. [499]Sencer,D. J.,and J. D. Millar. “Reflections on the 1976 Swine Flu Vaccination Program”. Emerging Infectious Diseases 12,no.1 (2006):29-33. [500]Shadrin,A. S.,I. G. Marinich,and L. Y. Taros. “Experimental and Epidemiological Estimation of Seasonal and Climato-Geographical Features of Non-Specific Resistance of the Organism to Influenza”. Journal of Hygiene,Epidemiology,Microbiology,and Immunology 21,no.2 (1977):155-61. [501]Shaman,J.,and A. Karspeck. “Forecasting Seasonal Outbreaks of Influenza”. Proceedings of the National Academy of Sciences 109,no.50 (2012):20425-30. [502]Shaman,J.,A. Karspeck,W. Yang,J. Tamerius,and M. Lipsitch. “Real-Time Influenza Forecasts during the 2012-2013 Season”. Nature Communications 4 (2013):2837. [503]Shanks,G. D.,S. Burroughs,J. D. Sohn,N. C. Waters,V. F. Smith,M. Waller,and J. F. Brundage. “Variable Mortality from the 1918-1919 Influenza Pandemic during Military Training”. Military Medicine 181,no.8 (2016):878-82. [504]Sherertz,R. J.,and H. J. Sherertz. “Influenza in the Preantibiotic Era”. Infectious Diseases in Clinical Practice 14,no.3 (2006):127. [505]Shortridge,K. F. “The 1918 ‘Spanish’ Flu:Pearls from Swine?” Nature Medicine 5,no.4 (1999):384-85. [506]Shrestha,S. S.,D. L. Swerdlow,R. H. Borse,V. S. Prabhu,L. Finelli,C. Y. Atkins,K. Owusu-Edusei et al. “Estimating the Burden of 2009 Pandemic Influenza A (H1N1)in the United States (April 2009-April 2010)”. Clinical Infectious Diseases 52,suppl.1 (2011):S75-82. [507]Shufflebotham,F. “Influenza among Poison Gas Workers”. British Medical Journal 1,no.3042 (1919):478-79. [508]Skowronski,D. M.,C. Chambers,G. De Serres,J. A. Dickinson,A. L. Winter,R. Hickman,T. Chan et al. “Early Season Co-circulation of Influenza A (H3N2)and B (Yamagata):Interim Estimates of 2017/18 Vaccine Effectiveness,Canada,January 2018”. Eurosurveillance 23,no.5 (2018):DOI:10.3201/eid1201.051254. [509]Smith,D. C. “Quinine and Fever:The Development of the Effective Dosage”. Journal of the History of Medicine and Allied Sciences 31,no.3 (1976):343-67. [510]Smith,D. W.,and B. S. Bradshaw. “Variation in Life Expectancy during the Twentieth Century in the United States”. Demography 43,no.4 (2006):647-57. [511]Smith,W.,C. Andrewes,and P. Laidlaw. “A Virus Obtained from Influenza Patients”. Lancet 2,no.5723 (1933):66-68. [512]Sneader,W. Drug Discovery:A History. Hoboken,NJ:Wiley & Sons,2005. [513]Sorbello,A.,S. C. Jones,W. Carter,K. Struble,R. Boucher,M. Truffa,D. Birnkrant et al. “Emergency Use Authorization for Intravenous Peramivir:Evaluation of Safety in the Treatment of Hospitalized Patients Infected with 2009 H1N1 Influenza A Virus”. Clinical Infectious Diseases 55,no.1 (2012):1-7. [514]Spurgeon,D. “Roche Canada Stops Distributing Oseltamivir”. British Medical Journal 331,no.7524 (2005):1041. [515]Starko,K. M. “Salicylates and Pandemic Influenza Mortality,1918-1919:Pharmacology,Pathology,and Historic Evidence”. Clinical Infectious Diseases 49,no.9 (2009):1405-10. [516]Stern,H. Theory and Practice of Bloodletting. New York:Rebman Company,1915. [517]Stoecker,C.,N. Sanders,and A. Barreca. “Success Is Something to Sneeze At:Influenza Mortality in Regions That Send Teams to the Super Bowl”. Tulane Economics Working Paper Series 2015;Working Paper 1501. [518]Sydenstricker,E. “The Incidence of Influenza among Persons of Different Economic Status during the Epidemic of 1918”. Public Health Reports 46,no.4 (1931):154-70. [519]Taubenberger,J. K. “The Origin and Virulence of the 1918 ‘Spanish’ InfluenzaVirus”. Proceedings of the American Philosophical Society 150,no.1 (2006):86-112. [520]Taubenberger,J. K.,J. V. Hultin,and D. M. Morens. “Discovery and Characterization of the 1918 Pandemic Influenza Virus in Historical Context”. Antiviral Therapy 12,no.4,part B (2007):581-91. [521]Taubenberger,J. K.,A. H. Reid,and T. G. Fanning. “Capturing a Killer Flu Virus.” Scientific American 292,no.1 (January 2005):62-71. [522]Taubenberger,J. K.,A. H. Reid,A. E. Krafft,K. E. Bijwaard,and T. G. Fanning. “Initial Genetic Characterization of the 1918 ‘Spanish’ Influenza Virus”. Science 275,no.5307 (1997):1793-96. [523]Taubenberger,J. K.,A. H. Reid,R. M. Lourens,R. Wang,G. Jin,and T. G. Fanning. “Characterization of the 1918 Influenza Virus Polymerase Genes”. Nature 437,no.7060 (2005):889-93. [524]Thompson,W. W.,D. K. Shay,E. Weintraub,L. Brammer,N. Cox,L. J. Anderson,and K. Fukuda. “Mortality Associated with Influenza and Respiratory Syncytial Virus in the United States”. JAMA 289,no.2 (2003):179-86. [525]Tiwari,Y.,S. Goel,and A. Singh. “Arrival Time Pattern and Waiting Time Distribution of Patients in the Emergency Outpatient Department of a Tertiary Level Health Care Institution of North India”. Journal of Emergencies,Trauma,and Shock 7,no.3 (2014):160-65. [526]Tumpey,T. M.,C. F. Basler,P. V. Aguilar,H. Zeng,A. Solorzano,D. E. Swayne,N. J. Cox et al. “Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus”. Science 310,no.5745 (2005):77-80. [527]“Undetermined Disease—Valencia”. Public Health Reports 33,no.26 (1918):1087. [528]Urashima,M.,T. Segawa,M. Okazaki,M. Kurihara,Y. Wada,and H. Ida. “Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza A in Schoolchildren”. American Journal of Clinical Nutrition 91,no.5 (2010):1255-60. [529]Valdivia,A.,J. Lopez-Alcalde,M. Vicente,M. Pichiule,M. Ruiz,and M. Ordobas. “Monitoring Influenza Activity in Europe with Google Flu Trends:Comparison with the Findings of Sentinel Physician Networks—Results for 2009-10”. Eurosurveillance 15,no.29 (2010):ii:19621. [530]Vaughan,V. C. Doctor’s Memories. New York:Bobbs-Merrill Company,1926. [531]Von Alvensleben,A. “Influenza According to Hoyle”. Nature 344,no.6265 (1990):374. [532]Watanabe,T.,G. Zhong,C. A. Russell,N. Nakajima,M. Hatta,A. Hanson,R.McBride,et al. “Circulating Avian Influenza Viruses Closely Related to the 1918 Virus Have Pandemic Potential”. Cell Host & Microbe 15,no.6 (2014):692-705. [533]Welch,S. J.,S. S. Jones,and T. Allen. “Mapping the 24-Hour Emergency Department Cycle to Improve Patient Flow”. Joint Commission Journal on Qualityand Patient Safety 33,no.5 (2007):247-55. [534]Welsch,R. A Treasury of Nebraska Pioneer Folklore. Lincoln:University of Nebraska Press,1967. [535]Winternitz,M. C.,I. M. Wason,and F. P. McNamara. The Pathology of Influenza. New Haven,CT:Yale University Press,1920. [536]Wootton,D. Bad Medicine:Doctors Doing Harm since Hippocrates. Oxford:Oxford University Press,2006. [537]Yamanouchi,T.,K. Sakakami,and S. Iwashima. “The Infecting Agent in Influenza:An Experimental Research”. Lancet 193,no.4997 (1919):971. [538]Yang,Y.,A. V. Diez Roux,and C. R. Bingham. “Variability and Seasonality of Active Transportation in USA:Evidence from the 2001 NHTS”. International Journal of Behavioral Nutrition and Physical Activity 8 (2011):96. [539]Zadshir,A.,N. Tareen,D. Pan,K. Norris,and D. Martins. “The Prevalence of Hypovitaminosis D among U.S. Adults:Data from the NHANES III”. Ethnicity & Disease 15,no.4,suppl.5 (2005):S5-97-101. [540]Zhang,X.,M. I. Meltzer,and P. M. Wortley. “FluSurge——a Tool to Estimate Demand for Hospital Services during the Next Pandemic Influenza”. Medical Decision Making 26,no.6 (2006):617-23.
[展开]

相关推荐

发表评论

同步转发到先晓茶馆

发表评论

手机可扫码阅读